DE60228997D1 - Zusammensetzungen und verfahren zur diagnose und behandlung eines tumors - Google Patents

Zusammensetzungen und verfahren zur diagnose und behandlung eines tumors

Info

Publication number
DE60228997D1
DE60228997D1 DE60228997T DE60228997T DE60228997D1 DE 60228997 D1 DE60228997 D1 DE 60228997D1 DE 60228997 T DE60228997 T DE 60228997T DE 60228997 T DE60228997 T DE 60228997T DE 60228997 D1 DE60228997 D1 DE 60228997D1
Authority
DE
Germany
Prior art keywords
polypeptides
present
methods
tumor
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60228997T
Other languages
English (en)
Inventor
Austin L Gurney
Mickey P Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21841414&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60228997(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US10/028,072 external-priority patent/US20030004311A1/en
Priority claimed from US10/119,480 external-priority patent/US20040087769A1/en
Application filed by Genentech Inc filed Critical Genentech Inc
Priority claimed from PCT/US2002/033050 external-priority patent/WO2003053334A2/en
Application granted granted Critical
Publication of DE60228997D1 publication Critical patent/DE60228997D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5061—Muscle cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
DE60228997T 2001-12-19 2002-10-16 Zusammensetzungen und verfahren zur diagnose und behandlung eines tumors Expired - Lifetime DE60228997D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/028,072 US20030004311A1 (en) 1997-06-18 2001-12-19 Secreted and transmembrane polypeptides and nucleic acids encoding the same
US10/119,480 US20040087769A1 (en) 1998-09-10 2002-04-09 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2002/033050 WO2003053334A2 (en) 2001-12-19 2002-10-16 Compositions and methods for the diagnosis and treatment of tumor

Publications (1)

Publication Number Publication Date
DE60228997D1 true DE60228997D1 (de) 2008-10-30

Family

ID=21841414

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60228997T Expired - Lifetime DE60228997D1 (de) 2001-12-19 2002-10-16 Zusammensetzungen und verfahren zur diagnose und behandlung eines tumors

Country Status (5)

Country Link
US (468) US20020137890A1 (de)
KR (1) KR20040074090A (de)
AT (1) ATE408419T1 (de)
DE (1) DE60228997D1 (de)
ZA (1) ZA200404849B (de)

Families Citing this family (171)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6300487B1 (en) * 1996-03-19 2001-10-09 Cell Therapuetics, Inc. Mammalian lysophosphatidic acid acyltransferase
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20060122373A1 (en) * 1997-04-04 2006-06-08 Millennium Pharmaceuticals, Inc. Delta3, FTHMA-070, Tango85, Tango77, SPOIL,NEOKINE, Tango129 and integrin alpha subunit protein and nucleic acid molecules and uses thereof
US20040141972A1 (en) 1997-11-21 2004-07-22 Genentech, Inc. Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
AU764441B2 (en) * 1998-02-09 2003-08-21 Genset S.A. cDNAs encoding secreted proteins
US20030175778A1 (en) * 1998-06-05 2003-09-18 Jian Ni Interferon Receptor HKAEF92
US20030211578A1 (en) * 1998-06-05 2003-11-13 Jian Ni Interferon receptor HKAEF92
US6699688B1 (en) * 1998-09-16 2004-03-02 The Research Foundation Of The State University Of New York Human platelet F11 receptor
WO2000018904A2 (en) * 1998-09-30 2000-04-06 Millennium Pharmaceuticals, Inc. Secreted proteins and nucleic acids encoding them
US7393823B1 (en) 1999-01-20 2008-07-01 Oregon Health And Science University HER-2 binding antagonists
US7396810B1 (en) * 2000-08-14 2008-07-08 Oregon Health Sciences University Compositions and methods for treating cancer by modulating HER-2 and EGF receptors
US7625859B1 (en) * 2000-02-16 2009-12-01 Oregon Health & Science University HER-2 binding antagonists
US7144996B1 (en) * 1999-03-05 2006-12-05 Genentech, Inc. Nucleic acid encoding human suppressor of fused
WO2000061610A2 (en) * 1999-04-12 2000-10-19 Agensys, Inc. Prostate-restricted gene 30p3c8 expressed in prostate cancer
US6468543B1 (en) 1999-05-03 2002-10-22 Zymogenetics, Inc. Methods for promoting growth of bone using ZVEGF4
US6630142B2 (en) 1999-05-03 2003-10-07 Zymogenetics, Inc. Method of treating fibroproliferative disorders
AUPQ206399A0 (en) * 1999-08-06 1999-08-26 Imr Worldwide Pty Ltd. Network user measurement system and method
US7842458B2 (en) 1999-08-12 2010-11-30 Agensys, Inc. Nucleic acids and corresponding proteins entitled 58P1D12 useful in treatment and detection of cancer
IL147902A0 (en) 1999-08-12 2002-08-14 Agensys Inc C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
US20030228288A1 (en) 1999-10-15 2003-12-11 Scarborough Nelson L. Volume maintaining osteoinductive/osteoconductive compositions
ATE478952T1 (de) * 1999-10-28 2010-09-15 Agensys Inc 36p6d5: ausgeschiedenes tumorprotein
US6639041B2 (en) * 1999-12-03 2003-10-28 Dupont-Toray Co. Ltd. Spandex having low set at low temperatures
US20010044525A1 (en) * 2000-01-05 2001-11-22 Conklin Darrell C. Novel FGF Homolog zFGF12
US20060160181A1 (en) * 2000-02-15 2006-07-20 Amgen Inc. Fibroblast Growth Factor-23 molecules and uses thereof
US20040081961A1 (en) * 2001-05-04 2004-04-29 Delegeane Angelo M Proteases
CA2407746A1 (en) * 2000-05-04 2001-11-08 Incyte Genomics, Inc. Proteases
MXPA02012717A (es) * 2000-06-21 2003-09-22 Amgen Inc Polipeptidos estromaticos-1 del colon, epiteliales, secretados, acidos nucleicos que los codifican y sus usos.
US9387094B2 (en) 2000-07-19 2016-07-12 Warsaw Orthopedic, Inc. Osteoimplant and method of making same
US8044259B2 (en) 2000-08-03 2011-10-25 The Regents Of The University Of Michigan Determining the capability of a test compound to affect solid tumor stem cells
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
EP1191097A1 (de) * 2000-09-21 2002-03-27 Leids Universitair Medisch Centrum Induktion von "exon-skipping" in eukaryotischen Zellen
US7323193B2 (en) 2001-12-14 2008-01-29 Osteotech, Inc. Method of making demineralized bone particles
CA2443123A1 (en) * 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
JP2005505351A (ja) 2001-10-12 2005-02-24 オステオテック インコーポレーテッド 改善された骨移植片
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
ATE384783T1 (de) * 2001-10-19 2008-02-15 Zymogenetics Inc Dimerisierter wachstumsfaktor sowie materialien und verfahren zu seiner herstellung
US7030018B2 (en) 2002-02-04 2006-04-18 Kla-Tencor Technologies Corp. Methods and systems for monitoring a parameter of a measurement device during polishing, damage to a specimen during polishing, or a characteristic of a polishing pad or tool
US7241593B2 (en) * 2002-02-11 2007-07-10 Zymogenetics, Inc. Materials and methods for preparing dimeric growth factors
US6993539B2 (en) 2002-03-19 2006-01-31 Network Appliance, Inc. System and method for determining changes in two snapshots and for transmitting changes to destination snapshot
EP1541677A4 (de) 2002-07-10 2007-06-27 Takeda Pharmaceutical Neue proteine und verwendung davon
US7126148B2 (en) * 2002-07-17 2006-10-24 The Johns Hopkins University Neutron detection based on boron activated liquid scintillation
DE10232329A1 (de) * 2002-07-17 2004-02-05 Daimlerchrysler Ag Kraftwagenkarosserie mit einer Strebenanordnung
AU2003279084A1 (en) * 2002-09-25 2004-04-19 Genentech, Inc. Novel compositions and methods for the treatment of psoriasis
US6890175B2 (en) * 2002-12-18 2005-05-10 Ultradent Products, Inc. Cooling system for hand-held curing light
JP2004267015A (ja) * 2003-03-05 2004-09-30 National Institute Of Advanced Industrial & Technology 核酸及び該核酸を用いた癌化検定方法
RS54160B1 (sr) 2003-03-19 2015-12-31 Biogen Idec Ma Inc. Protein koji se vezuje za nogo receptor
WO2004083432A1 (en) 2003-03-21 2004-09-30 Academisch Ziekenhuis Leiden Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
CA2528086C (en) * 2003-06-11 2013-01-08 Osteotech, Inc. Osteoimplants and methods for their manufacture
JP4054727B2 (ja) * 2003-07-14 2008-03-05 株式会社リコー 出力バッファ回路及び出力バッファ回路を使用したインタフェース回路
US20070178458A1 (en) * 2003-09-05 2007-08-02 O'brien Philippa Methods of diagnosis and prognosis of ovarian cancer II
EP1560025A3 (de) * 2003-10-03 2011-09-07 F. Hoffmann-La Roche AG Marker spezifisch für Diabetes
EP1694864A2 (de) * 2003-11-20 2006-08-30 Genentech, Inc. Zusammensetzungen und verfahren für die tumor-diagnose und behandlung
WO2005075511A1 (en) * 2004-01-29 2005-08-18 Genentech, Inc. Variants of the extracellular domain of bcma and uses thereof
ATE549352T1 (de) * 2004-02-20 2012-03-15 Develogen Ag Verwendung sekretierter proteinprodukte zur prävention und behandlung von erkrankungen der bauchspeicheldrüse und/oder adipositas und/oder des metabolischen syndroms
DE102004010203B4 (de) * 2004-03-02 2007-05-10 Siemens Ag Verfahren, Vorrichtung und Computerprogramm zur Erstellung einer Projektierung für ein Bediengerät einer Automatisierungskomponente
WO2005089799A1 (ja) * 2004-03-24 2005-09-29 Oncotherapy Science, Inc. Fam3dに対する抗体のエフェクター機能による細胞障害方法
US20050214303A1 (en) * 2004-03-24 2005-09-29 Oncotherapy Science, Inc. Methods for damaging cells using effector functions of anti FAM3D antibodies
US7659915B2 (en) * 2004-04-02 2010-02-09 K-Nfb Reading Technology, Inc. Portable reading device with mode processing
CA2563445C (en) 2004-04-14 2016-07-19 Genentech, Inc. Compositions and methods for modulating vascular development
US20080038730A1 (en) * 2004-05-10 2008-02-14 Heinz Von Der Kammer Diagnostic and Therapeutic Use of Kcnj6 for Alzheimer's Disease
EP1751188A1 (de) * 2004-06-04 2007-02-14 Applied Research Systems ARS Holding N.V. Eine spleissvariante von unc5h2
KR101239542B1 (ko) 2004-06-24 2013-03-07 바이오겐 아이덱 엠에이 인코포레이티드 탈수초화를 수반하는 병의 치료
WO2006005459A2 (en) * 2004-07-15 2006-01-19 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with thyrotropin-releasing hormone degrading ectoenzyme (trhde)
KR101254815B1 (ko) * 2004-07-20 2013-09-03 제넨테크, 인크. 안지오포이에틴-유사 4 단백질의 저해제, 배합물, 그의용도
CN101080419B (zh) * 2004-07-20 2014-07-02 健泰科生物技术公司 利用血管生成素样4蛋白的组合物和方法
US8604185B2 (en) 2004-07-20 2013-12-10 Genentech, Inc. Inhibitors of angiopoietin-like 4 protein, combinations, and their use
EP2311953A1 (de) * 2004-08-04 2011-04-20 Riken Knochen-/Gelenkerkrankungsempfänglichkeitsgen und Verwendung davon
EP1778284B1 (de) * 2004-08-16 2012-04-25 Agensys, Inc. Nukleinsäuren und entsprechende proteine 58p1d12 zum nachweis von krebs
EP1807106A2 (de) * 2004-10-05 2007-07-18 Oregon Health and Science University Zusammensetzungen und verfahren zur behandlung von erkrankungen
US7938307B2 (en) * 2004-10-18 2011-05-10 Tyco Healthcare Group Lp Support structures and methods of using the same
US20060155862A1 (en) * 2005-01-06 2006-07-13 Hari Kathi Data traffic load balancing based on application layer messages
WO2006076712A2 (en) * 2005-01-14 2006-07-20 Osteotech, Inc. Expandable osteoimplant
CA2593351A1 (en) * 2005-01-27 2006-08-03 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP1882712B1 (de) 2005-04-22 2010-04-21 Mitsubishi Chemical Corporation Aus biomasseressourcen gewonnener polyester und herstellungsverfahren dafür
EP1885872A4 (de) * 2005-04-25 2009-03-25 Univ Yamanashi Zusammensetzungen und verfahren zur behandlung von mit clec-2-signaltransduktion assoziierten hämostasestörungen
RS53058B (en) 2005-07-08 2014-04-30 Biogen Idec Ma Inc. SP35 ANTIBODIES AND THEIR APPLICATIONS
EP1922410A2 (de) * 2005-08-15 2008-05-21 Genentech, Inc. Genunterbrechungen, zusammensetzungen und verfahren in verbindung damit
ZA200800969B (en) * 2005-08-16 2009-08-26 Genentech Inc Apoptosis sensitivity to APO2L/TRAIL by testing for GalNac-T14 expression in cells/tissues
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
DE602006015985D1 (de) 2005-09-30 2010-09-16 Philadelphia Health & Educatio Antigene gegen das leberstadium von plasmodium
ES2547421T3 (es) 2005-10-31 2015-10-06 Oncomed Pharmaceuticals, Inc. Composiciones y métodos para diagnosticar y tratar el cáncer
US7723477B2 (en) 2005-10-31 2010-05-25 Oncomed Pharmaceuticals, Inc. Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
WO2007056671A1 (en) * 2005-11-02 2007-05-18 Osteotech, Inc. Hemostatic bone graft
US7293487B2 (en) * 2005-11-15 2007-11-13 3M Innovative Properties Company Cutting tool having variable and independent movement in an x-direction and a z-direction into and laterally along a work piece for making microstructures
JP2009515997A (ja) * 2005-11-18 2009-04-16 タケダ サン ディエゴ インコーポレイテッド グルコキナーゼ活性剤
WO2007084487A2 (en) * 2006-01-13 2007-07-26 Wayne State University Pericytes for use as stem cells
JP5302012B2 (ja) 2006-03-08 2013-10-02 タケダ カリフォルニア インコーポレイテッド グルコキナーゼ活性剤
WO2007123391A1 (en) * 2006-04-20 2007-11-01 Academisch Ziekenhuis Leiden Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly expressed gene.
EP1857548A1 (de) * 2006-05-19 2007-11-21 Academisch Ziekenhuis Leiden Mittel und Verfahren zur Induktion von Exon-skipping
WO2007143434A2 (en) 2006-05-31 2007-12-13 Takeda San Diego, Inc. Indazole and isoindole derivatives as glucokinase activating agents
CA2660523C (en) 2006-08-11 2019-03-19 Prosensa Technologies B.V. Methods and means for treating dna repeat instability associated genetic disorders
EA018260B1 (ru) * 2006-09-29 2013-06-28 Онкомед Фармасьютикалз, Инк. Антитела к дельта-подобному лиганду 4 человека и их применение
US7875747B2 (en) * 2006-10-10 2011-01-25 Afton Chemical Corporation Branched succinimide dispersant compounds and methods of making the compounds
CA2666498A1 (en) * 2006-10-20 2008-10-23 Schrader Electronics Ltd. Method for detecting and correcting data errors in an rf data link
CA2663523A1 (en) * 2006-11-14 2008-10-23 Genentech, Inc. Novel gene disruptions, compositions and methods relating thereto
US8163779B2 (en) 2006-12-20 2012-04-24 Takeda San Diego, Inc. Glucokinase activators
US7980000B2 (en) 2006-12-29 2011-07-19 Applied Materials, Inc. Vapor dryer having hydrophilic end effector
US8128926B2 (en) 2007-01-09 2012-03-06 Biogen Idec Ma Inc. Sp35 antibodies and uses thereof
EP2106439B1 (de) 2007-01-24 2014-11-12 The Regents of the University of Michigan Zusammensetzungen und verfahren zur behandlung und diagnostizierung von pankreaskrebs
EP1961849A1 (de) * 2007-02-22 2008-08-27 ALBIS Spa Vorverfestigte Spinnvliesbahn, Verbundvlies mit vorverfestigter Spinnvliesbahn, Verfahren und kontinuierliches System zur Herstellung dieses Verbundstoffes
GB0704396D0 (en) * 2007-03-07 2007-04-11 Royal Bank Of Scotland Plc The Cash dispensing methods and systems
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators
US20080240081A1 (en) * 2007-03-30 2008-10-02 Texas Instruments Incorporated Method, system and apparatus for providing rules-based restriction of incoming calls
US7705085B2 (en) * 2007-04-06 2010-04-27 3M Innovative Properties Company Fluoroelastomer composition for cold shrink articles
EP2167135A2 (de) * 2007-07-12 2010-03-31 Prosensa Technologies B.V. Moleküle für targeting von verbindungen auf verschiedene ausgewählte organe, gewebe oder tumorzellen
CA2693048C (en) * 2007-07-12 2016-10-18 Prosensa Technologies B.V. Molecules for targeting compounds to various selected organs or tissues
US8103302B2 (en) * 2007-09-11 2012-01-24 Telefonaktiebolaget Lm Ericsson (Publ) Power-aware link adaptation with variable bandwidth allocation
WO2009046123A2 (en) * 2007-10-02 2009-04-09 Genentech, Inc. Nlrr-1 antagonists and uses thereof
US20110020786A1 (en) * 2007-10-08 2011-01-27 Baylor College Of Medicine Peptide dendrimers: affinity reagents for binding noroviruses
CN101980603A (zh) * 2007-10-11 2011-02-23 比奥根艾迪克Ma公司 LINGO-1和TrkB拮抗剂的用途
HUE028662T2 (en) 2007-10-26 2016-12-28 Academisch Ziekenhuis Leiden Preparations and methods for controlling muscle disorders
USRE48468E1 (en) 2007-10-26 2021-03-16 Biomarin Technologies B.V. Means and methods for counteracting muscle disorders
AU2008325107B2 (en) * 2007-11-08 2015-04-23 Biogen Ma Inc. Use of LINGO-4 antagonists in the treatment of conditions involving demyelination
WO2009099326A1 (en) * 2008-02-08 2009-08-13 Prosensa Holding Bv Methods and means for treating dna repeat instability associated genetic disorders
EP2119783A1 (de) 2008-05-14 2009-11-18 Prosensa Technologies B.V. Verfahren für effizientes Exon (44)-Skipping bei Duchenne-Muskeldystrophie und entsprechende Mittel
DK2982695T3 (da) * 2008-07-09 2019-05-13 Biogen Ma Inc Sammensætninger, der omfatter antistoffer mod lingo eller fragmenter deraf
US20100047166A1 (en) * 2008-08-20 2010-02-25 Kanner Steven B Antibodies and related molecules that bind to 58p1d12 proteins
EP2326669A2 (de) * 2008-09-04 2011-06-01 Oxford Biotherapeutics Ltd. Pta072-protein
NZ592338A (en) 2008-09-26 2012-11-30 Oncomed Pharm Inc Frizzled-binding agents and uses thereof
AU2009308191A1 (en) 2008-10-24 2010-04-29 Warsaw Orthopedic, Inc. Compositions and methods for promoting bone formation
JP2010225758A (ja) * 2009-03-23 2010-10-07 Fuji Xerox Co Ltd 有機半導体トランジスタ
WO2010123369A1 (en) 2009-04-24 2010-10-28 Prosensa Technologies B.V. Oligonucleotide comprising an inosine for treating dmd
PE20120902A1 (es) 2009-05-08 2012-08-08 Genentech Inc Anticuerpos anti-egfl7 humanizados
JP2012526563A (ja) * 2009-05-15 2012-11-01 インサイト ジェネティクス インコーポレイテッド 癌を診断および治療するためのａｌｋの融合に関する方法および組成物
KR101640633B1 (ko) 2009-08-28 2016-07-18 솔레니스 테크놀러지스 케이맨, 엘.피. 안정적인 산 변성된 대두/우레아 접착제 및 그의 제조 방법
ES2567030T3 (es) 2009-09-03 2016-04-19 Cancer Research Technology Limited Inhibidores de CLEC14A
US20110086806A1 (en) * 2009-10-09 2011-04-14 Anaphore, Inc. Polypeptides that Bind IL-23R
JP5965318B2 (ja) 2009-10-16 2016-08-03 オンコメッド ファーマシューティカルズ インコーポレイテッド Ｄｌｌ４アンタゴニストおよび降圧剤の治療的併用およびそれらによる治療の方法
EP2494351B1 (de) 2009-10-26 2016-06-08 Externautics S.p.A. Kolon- und rektaltumormarker sowie verfahren zu ihrer verwendung
EP3345920A1 (de) 2009-10-26 2018-07-11 Externautics S.p.A. Brustkrebsmarker und verfahren zur verwendung davon
EP2493916B1 (de) 2009-10-26 2016-06-08 Externautics S.p.A. Marker für lungentumore und deren verwendung
US9134323B2 (en) 2009-12-01 2015-09-15 The Rockefeller University Antibody that specifically binds to an epitope in the tureet region of a human Kir channel
EP2506875A4 (de) * 2009-12-01 2013-11-27 Oncomed Pharm Inc Verfahren zur behandlung von tumoren mit k-ras-mutationen
GB0922085D0 (en) * 2009-12-17 2010-02-03 Cambridge Entpr Ltd Cancer diagnosis and treatment
WO2011078672A1 (en) 2009-12-24 2011-06-30 Prosensa Technologies B.V. Molecule for treating an inflammatory disorder
TWI535445B (zh) 2010-01-12 2016-06-01 安可美德藥物股份有限公司 Ｗｎｔ拮抗劑及治療和篩選方法
AU2011235904B2 (en) 2010-04-01 2015-10-08 Oncomed Pharmaceuticals, Inc. Frizzled-binding agents and uses thereof
MX2012011688A (es) * 2010-04-09 2012-11-23 Amgen Inc Proteinas btnl9, acidos nucleicos y anticuerpos y usos de los mismos.
US9139629B2 (en) 2010-06-05 2015-09-22 The Uab Research Foundation Methods for treatment of nephrotic syndrome and related conditions
US20110301103A1 (en) 2010-06-05 2011-12-08 Chugh Sumant S Methods of Treatment
US8551479B2 (en) 2010-09-10 2013-10-08 Oncomed Pharmaceuticals, Inc. Methods for treating melanoma
CN102569428B (zh) * 2010-12-21 2015-06-03 上海华虹宏力半导体制造有限公司 纵向电压控制变容器及其制备方法
HRP20230078T1 (hr) 2011-09-23 2023-05-12 Mereo Biopharma 5, Inc. Sredstva za vezivanje vegf/dll4 i njihova uporaba
WO2013059426A1 (en) * 2011-10-21 2013-04-25 The Regents Of The University Of California Human endogenous retrovirus peptides, antibodies to the peptides, and methods of use thereof
US9443007B2 (en) 2011-11-02 2016-09-13 Salesforce.Com, Inc. Tools and techniques for extracting knowledge from unstructured data retrieved from personal data sources
ITUD20110196A1 (it) * 2011-12-02 2013-06-03 Asoltech S R L Composizione a base di ubidecarenone
CA2862628C (en) 2012-01-27 2021-08-24 Prosensa Technologies B.V. Rna modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy
NZ702178A (en) 2012-05-14 2017-01-27 Biogen Ma Inc Lingo-2 antagonists for treatment of conditions involving motor neurons
US20140035949A1 (en) * 2012-08-03 2014-02-06 Tempo Ai, Inc. Method and apparatus for enhancing a calendar view on a device
US9266959B2 (en) 2012-10-23 2016-02-23 Oncomed Pharmaceuticals, Inc. Methods of treating neuroendocrine tumors using frizzled-binding agents
CA2889638A1 (en) 2012-10-31 2014-05-08 Oncomed Pharmaceuticals, Inc. Methods and monitoring of treatment with a dll4 antagonist
US9359444B2 (en) 2013-02-04 2016-06-07 Oncomed Pharmaceuticals Inc. Methods and monitoring of treatment with a Wnt pathway inhibitor
US9168300B2 (en) 2013-03-14 2015-10-27 Oncomed Pharmaceuticals, Inc. MET-binding agents and uses thereof
EP2970484B2 (de) 2013-03-15 2022-09-21 Amgen Inc. Heterodimere bispezifische antikörper
EP3733710A1 (de) 2013-09-25 2020-11-04 Amgen, Inc Heterodimeriche v-c-fc-v-c-antikörper
US10367649B2 (en) 2013-11-13 2019-07-30 Salesforce.Com, Inc. Smart scheduling and reporting for teams
WO2016046778A2 (en) 2014-09-25 2016-03-31 Amgen Inc Protease-activatable bispecific proteins
US20160176962A1 (en) 2014-10-31 2016-06-23 Oncomed Pharmaceuticals, Inc. Combination Therapy For Treatment Of Disease
AU2016205197B2 (en) 2015-01-08 2021-10-21 Biogen Ma Inc. LINGO-1 antagonists and uses for treatment of demyelinating disorders
PL3347376T3 (pl) 2015-09-07 2021-12-06 Heiko LICKERT Nowy receptor IGFR-podobny i jego zastosowania
ES2968074T3 (es) 2015-09-23 2024-05-07 Mereo Biopharma 5 Inc Anticuerpo bi-específico anti-VEGF/DLL4 para su uso en el tratamiento del cáncer de ovario resistente al platino
US20180061660A1 (en) * 2016-08-26 2018-03-01 Infineon Technologies Ag Barrier Layer Formation Using Thermal Processing
WO2018075621A1 (en) * 2016-10-19 2018-04-26 Vanderbilt University Human orthopoxvirus antibodies and methods of use therefor
US11634486B2 (en) 2016-12-23 2023-04-25 Bluefin Biomedicine, Inc. Anti-SEZ6L2 antibodies and antibody drug conjugates
US20180196053A1 (en) * 2017-01-10 2018-07-12 Chang Gung Memorial Hospital, Linkou Methods and kits for detecting cancer
US11043305B1 (en) * 2018-02-02 2021-06-22 Immuneering Corporation Systems and methods for rapid gene set enrichment analysis
AU2019369498A1 (en) * 2018-10-31 2021-05-20 Delinia, Inc. Multivalent regulatory T cell modulators
MX2021015045A (es) 2019-06-07 2022-03-17 Amgen Inc Construcciones de unión biespecíficas.
US20230203198A1 (en) 2020-06-04 2023-06-29 Amgen Inc. Bispecific binding constructs
CN116783217A (zh) 2020-12-03 2023-09-19 安进公司 具有多个结合结构域的免疫球蛋白构建体

Family Cites Families (363)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US553637A (en) * 1896-01-28 bagnall
US2929866A (en) * 1953-10-30 1960-03-22 Westinghouse Electric Corp Television pickup tube
GB937358A (en) * 1961-11-13 1963-09-18 Marconi Wireless Telegraph Co Improvements in or relating to television scanning systems
JPS4844279B1 (de) * 1965-05-08 1973-12-24
US3515800A (en) * 1966-05-10 1970-06-02 Victor Company Of Japan Television camera for selectively picking up scenes in color or monochromatically
US3654090A (en) * 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
US3783190A (en) * 1971-04-08 1974-01-01 Gte Sylvania Inc Aperture correction circuit for low light level television camera
JPS5110986B2 (de) * 1972-10-05 1976-04-08
GB1415827A (en) * 1973-03-31 1975-11-26 Schumacher Klimsch Co E Photomechanical reproduction
US4256833A (en) * 1979-01-08 1981-03-17 Majid Ali Enzyme immunoassay for allergic disorders
JPS57108866A (en) * 1980-12-26 1982-07-07 Fuji Xerox Co Ltd Dichromatic copying machine
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4433346A (en) * 1982-03-31 1984-02-21 Xerox Corporation Raster input scanner
US4491865A (en) * 1982-09-29 1985-01-01 Welch Allyn, Inc. Image sensor assembly
US4516153A (en) * 1983-03-30 1985-05-07 Rca Corporation Composite video signal processing apparatus providing amplitude equalization
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DE3429548A1 (de) * 1983-08-24 1985-05-15 Kabushiki Kaisha Toshiba, Kawasaki, Kanagawa Farbsteuereinheit fuer ein bilderzeugungsgeraet
KR850004274A (ko) * 1983-12-13 1985-07-11 원본미기재 에리트로포이에틴의 제조방법
US4608606A (en) * 1984-03-15 1986-08-26 Rca Corporation CCD floating-element output stages providing low reset noise with single sampling
US4658956A (en) * 1984-05-30 1987-04-21 El Planning System Ltd. Portable case for a small size audio-visual sensory apparatus
JPS612957A (ja) * 1984-06-18 1986-01-08 Toyota Motor Corp 無段変速機付き動力伝達装置の油圧制御装置
JPS6147919A (ja) * 1984-08-15 1986-03-08 Olympus Optical Co Ltd 内視鏡用撮像光学系
JPS6142513U (ja) * 1984-08-23 1986-03-19 富士写真光機株式会社 内視鏡
US4599116A (en) * 1984-11-08 1986-07-08 Parker Chemical Company Alkaline cleaning process
US4879224A (en) * 1985-01-10 1989-11-07 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor polypeptides
WO1987001246A1 (en) * 1985-08-13 1987-02-26 Robert Joseph Mears Fibre-optic lasers and amplifiers
JPH0522897Y2 (de) * 1985-08-16 1993-06-11
JP2679014B2 (ja) * 1986-03-19 1997-11-19 オリンパス光学工業株式会社 電子内視鏡装置
JPS6365840A (ja) * 1986-04-04 1988-03-24 オリンパス光学工業株式会社 内視鏡
US4735501A (en) * 1986-04-21 1988-04-05 Identechs Corporation Method and apparatus for fluid propelled borescopes
JPH0664243B2 (ja) * 1986-04-30 1994-08-22 オリンパス光学工業株式会社 内視鏡
DE3715417A1 (de) * 1986-05-13 1987-11-19 Olympus Optical Co Halbleiter-bilderzeugungsvorrichtung, sowie hiermit ausgestattetes endoskop
JPS635722A (ja) * 1986-06-25 1988-01-11 オリンパス光学工業株式会社 内視鏡
JP2812940B2 (ja) * 1986-09-01 1998-10-22 オリンパス光学工業株式会社 内視鏡
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5013652A (en) * 1986-10-14 1991-05-07 Genex Corporation Composite yeast vectors
US4733937A (en) * 1986-10-17 1988-03-29 Welch Allyn, Inc. Illuminating system for endoscope or borescope
US4758891A (en) * 1986-10-20 1988-07-19 North American Philips Consumer Electronics Corp. Method and apparatus for improving the rise and fall time of a video signal
US4895431A (en) * 1986-11-13 1990-01-23 Olympus Optical Co., Ltd. Method of processing endoscopic images
US5011912A (en) * 1986-12-19 1991-04-30 Immunex Corporation Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
US4727859A (en) * 1986-12-29 1988-03-01 Welch Allyn, Inc. Right angle detachable prism assembly for borescope
US4918521A (en) * 1987-01-20 1990-04-17 Olympus Optical Co., Ltd. Solid state imaging apparatus
JPS63316476A (ja) * 1987-06-18 1988-12-23 Seiko Instr & Electronics Ltd 半導体装置およびその製造方法
US4796607A (en) * 1987-07-28 1989-01-10 Welch Allyn, Inc. Endoscope steering section
US4794912A (en) * 1987-08-17 1989-01-03 Welch Allyn, Inc. Borescope or endoscope with fluid dynamic muscle
US4786609A (en) * 1987-10-05 1988-11-22 North American Philips Corporation, Signetics Division Method of fabricating field-effect transistor utilizing improved gate sidewall spacers
US5021888A (en) * 1987-12-18 1991-06-04 Kabushiki Kaisha Toshiba Miniaturized solid state imaging device
JP2594627B2 (ja) * 1988-02-26 1997-03-26 オリンパス光学工業株式会社 電子内視鏡装置
US5583103A (en) * 1988-06-28 1996-12-10 La Jolla Cancer Research Foundation Inhibition of transforming growth factor beta activity
US5654270A (en) * 1988-06-28 1997-08-05 La Jolla Cancer Research Foundation Use of fibromodulin to prevent or reduce dermal scarring
US4862253A (en) * 1988-07-20 1989-08-29 Welch Allyn, Inc. Apparatus for converting a video processor
US5089473A (en) * 1988-08-29 1992-02-18 Monsanto Company Somatotropin variants and their use
US4909600A (en) * 1988-10-28 1990-03-20 Welch Allyn, Inc. Light chopper assembly
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5968778A (en) * 1989-01-12 1999-10-19 Jurgen Hoppe PDGF-AB, preparation process and pharmaceuticals containing them
JP2751320B2 (ja) * 1989-02-21 1998-05-18 日本電気株式会社 エミッタホロワ回路
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
US4993405A (en) * 1989-05-15 1991-02-19 Olympus Optical Co., Ltd. Imaging apparatus
US5014515A (en) * 1989-05-30 1991-05-14 Welch Allyn, Inc. Hydraulic muscle pump
US4913369A (en) * 1989-06-02 1990-04-03 Welch Allyn, Inc. Reel for borescope insertion tube
JPH0323832A (ja) * 1989-06-22 1991-01-31 Toshiba Corp 電子内視鏡装置
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
US4941454A (en) * 1989-10-05 1990-07-17 Welch Allyn, Inc. Servo actuated steering mechanism for borescope or endoscope
US4941456A (en) * 1989-10-05 1990-07-17 Welch Allyn, Inc. Portable color imager borescope
FR2654258A1 (fr) * 1989-11-03 1991-05-10 Philips Nv Procede pour fabriquer un dispositif a transistor mis ayant une electrode de grille en forme de "t" inverse.
JP2579372B2 (ja) * 1989-12-04 1997-02-05 日本テキサス・インスツルメンツ株式会社 低消費電力撮像装置
US4971655A (en) * 1989-12-26 1990-11-20 Micron Technology, Inc. Protection of a refractory metal silicide during high-temperature processing using a dual-layer cap of silicon dioxide and silicon nitride
WO1991010727A1 (en) 1990-01-22 1991-07-25 La Jolla Cancer Research Foundation Inhibitors of cell regulatory factors
US5014600A (en) * 1990-02-06 1991-05-14 Welch Allyn, Inc. Bistep terminator for hydraulic or pneumatic muscle
US4998182A (en) * 1990-02-08 1991-03-05 Welch Allyn, Inc. Connector for optical sensor
US4981810A (en) * 1990-02-16 1991-01-01 Micron Technology, Inc. Process for creating field effect transistors having reduced-slope, staircase-profile sidewall spacers
US5536638A (en) * 1990-04-18 1996-07-16 N.V. Innogenetics S.A. Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of Neisseria gonorrhoeae
US5126283A (en) * 1990-05-21 1992-06-30 Motorola, Inc. Process for the selective encapsulation of an electrically conductive structure in a semiconductor device
US5019121A (en) * 1990-05-25 1991-05-28 Welch Allyn, Inc. Helical fluid-actuated torsional motor
US4989581A (en) * 1990-06-01 1991-02-05 Welch Allyn, Inc. Torsional strain relief for borescope
US5018506A (en) * 1990-06-18 1991-05-28 Welch Allyn, Inc. Fluid controlled biased bending neck
US5203319A (en) * 1990-06-18 1993-04-20 Welch Allyn, Inc. Fluid controlled biased bending neck
JPH0456341A (ja) * 1990-06-26 1992-02-24 Matsushita Electric Ind Co Ltd 半導体集積回路のレイアウト方法
US5306655A (en) * 1990-07-24 1994-04-26 Matsushita Electric Industrial Co., Ltd. Structure and method of manufacture for MOS field effect transistor having lightly doped drain and source diffusion regions
US5114636A (en) * 1990-07-31 1992-05-19 Welch Allyn, Inc. Process for reducing the internal cross section of elastomeric tubing
US5018436A (en) * 1990-07-31 1991-05-28 Welch Allyn, Inc. Folded bladder for fluid dynamic muscle
JP3216650B2 (ja) * 1990-08-27 2001-10-09 オリンパス光学工業株式会社 固体撮像装置
JPH0817235B2 (ja) * 1990-08-29 1996-02-21 株式会社東芝 オフセットゲート構造トランジスタおよびその製造方法
US5418566A (en) * 1990-09-10 1995-05-23 Kabushiki Kaisha Toshiba Compact imaging apparatus for electronic endoscope with improved optical characteristics
DE4037837A1 (de) * 1990-11-28 1992-06-04 Behringwerke Ag Zellfreie rezeptorbindungsteste, ihre herstellung und verwendung
WO1992010518A1 (en) 1990-12-07 1992-06-25 Yale University Purified slit protein and sequence elements thereof
EP0490535B1 (de) * 1990-12-07 1996-08-21 AT&T Corp. Feldeffekttransistor mit inverser T-förmiger Silizid-Torelektrode
US5291151A (en) * 1991-01-19 1994-03-01 Canon Kabushiki Kaisha Sensor amplifier
US5994088A (en) * 1991-03-08 1999-11-30 Board Of Trustees Of The University Of Illinois Methods and reagents for preparing and using immunological agents specific for P-glycoprotein
JP3078085B2 (ja) * 1991-03-26 2000-08-21 オリンパス光学工業株式会社 画像処理装置および画像処理方法
JPH0595900A (ja) * 1991-04-11 1993-04-20 Olympus Optical Co Ltd 内視鏡画像処理装置
US5417210A (en) * 1992-05-27 1995-05-23 International Business Machines Corporation System and method for augmentation of endoscopic surgery
KR940006702B1 (ko) * 1991-06-14 1994-07-25 금성일렉트론 주식회사 모스패트의 제조방법
US5191879A (en) * 1991-07-24 1993-03-09 Welch Allyn, Inc. Variable focus camera for borescope or endoscope
KR960000225B1 (ko) * 1991-08-26 1996-01-03 가부시키가이샤 한도오따이 에네루기 겐큐쇼 절연게이트형 반도체장치의 제작방법
US5314834A (en) * 1991-08-26 1994-05-24 Motorola, Inc. Field effect transistor having a gate dielectric with variable thickness
US5445940A (en) * 1991-08-28 1995-08-29 Brigham & Women's Hospital Methods and compositions for detecting and treating a subset of human patients having an autoimmune disease
US5202758A (en) * 1991-09-16 1993-04-13 Welch Allyn, Inc. Fluorescent penetrant measurement borescope
US5565332A (en) * 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
JP3067347B2 (ja) * 1991-10-30 2000-07-17 株式会社島津製作所 ゲル状ビーズの選別装置
US5187759A (en) * 1991-11-07 1993-02-16 At&T Bell Laboratories High gain multi-mode optical amplifier
US5932211A (en) * 1991-11-12 1999-08-03 Women's And Children's Hospital Glycosylation variants of iduronate 2-sulfatase
US5817310A (en) * 1991-12-02 1998-10-06 Cor Therapeutics, Inc. Inhibitory immunoglobulin polypeptides to human PDGF beta receptor
US5614943A (en) * 1991-12-19 1997-03-25 Olympus Optical Co., Ltd. Dissimilar endoscopes usable with a common control unit
US5278642A (en) * 1992-02-26 1994-01-11 Welch Allyn, Inc. Color imaging system
US5441883A (en) * 1992-03-03 1995-08-15 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University A3 adenosine receptor, DNA, and uses
GB2264948B (en) * 1992-03-13 1996-10-16 Merck & Co Inc Human adenosine receptors
US5569662A (en) 1992-03-23 1996-10-29 Pfizer Inc. Quinuclidine derivatives as substance P antagonists
DE4211547C2 (de) * 1992-04-06 1994-08-11 Henke Sass Wolf Gmbh Schutzabdeckung für das distale Ende von Endoskopen
US5306951A (en) * 1992-05-14 1994-04-26 Micron Technology, Inc. Sidewall silicidation for improved reliability and conductivity
US5762959A (en) * 1992-05-29 1998-06-09 Vivorx, Inc. Microencapsulation of cells
US5429821A (en) * 1992-05-29 1995-07-04 The Regents Of The University Of California Non-fibrogenic high mannuronate alginate coated transplants, processes for their manufacture, and methods for their use
AU681855B2 (en) 1992-06-22 1997-09-11 Matritech, Inc. Novel malignant cell type markers of the interior nuclear matrix
US5874082A (en) * 1992-07-09 1999-02-23 Chiron Corporation Humanized anti-CD40 monoclonal antibodies and fragments capable of blocking B cell proliferation
GB9214857D0 (en) * 1992-07-13 1992-08-26 Medical Res Council Human nucleic acid fragments and their use
US5275152A (en) * 1992-07-27 1994-01-04 Welch Allyn, Inc. Insertion tube terminator
DE69332485T2 (de) * 1992-08-11 2003-11-13 Harvard College Immunmodulierende peptide
US5480805A (en) * 1992-08-12 1996-01-02 Amoco Corporation Composition for modulating sterols in yeast
US5322807A (en) * 1992-08-19 1994-06-21 At&T Bell Laboratories Method of making thin film transistors including recrystallization and high pressure oxidation
JP3472587B2 (ja) * 1992-08-28 2003-12-02 アベンティス ファーマ株式会社 骨関連カルボキシペプチダーゼ様タンパク質およびその製造法
JPH06121678A (ja) * 1992-08-28 1994-05-06 Hoechst Japan Ltd 骨関連サルファターゼ様タンパク質およびその製造法
US5262352A (en) * 1992-08-31 1993-11-16 Motorola, Inc. Method for forming an interconnection structure for conductive layers
EP0672131B1 (de) * 1992-10-30 2003-12-17 The General Hospital Corporation Ein neues zellzyklus kontrollprotein
KR970011744B1 (ko) * 1992-11-04 1997-07-15 마쯔시다덴기산교 가부시기가이샤 상보형 반도체장치 및 그 제조방법
KR950011983B1 (ko) * 1992-11-23 1995-10-13 삼성전자주식회사 반도체 장치의 제조방법
US5371026A (en) * 1992-11-30 1994-12-06 Motorola Inc. Method for fabricating paired MOS transistors having a current-gain differential
US5314070A (en) * 1992-12-16 1994-05-24 Welch Allyn, Inc. Case for flexible borescope and endoscope insertion tubes
JP3220538B2 (ja) * 1992-12-24 2001-10-22 オリンパス光学工業株式会社 立体視内視鏡及び立体視内視鏡装置
US5798224A (en) * 1992-12-29 1998-08-25 Doheny Eye Institute Nucleic acids encoding protocadherin
JPH06214354A (ja) * 1993-01-14 1994-08-05 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料及びその処理方法
US5293836A (en) * 1993-01-15 1994-03-15 Ziggity Systems, Inc. Water retaining trigger pin
US5386344A (en) * 1993-01-26 1995-01-31 International Business Machines Corporation Flex circuit card elastomeric cable connector assembly
US5633675A (en) * 1993-02-16 1997-05-27 Welch Allyn, Inc, Shadow probe
US5674182A (en) * 1993-02-26 1997-10-07 Olympus Optical Co., Ltd. Endoscope system including endoscope and protection cover
USD358471S (en) * 1993-03-11 1995-05-16 Welch Allyn, Inc. Combined control handle and viewing screen for an endoscope
US5334556A (en) * 1993-03-23 1994-08-02 Texas Instruments Incorporated Method for improving gate oxide integrity using low temperature oxidation during source/drain anneal
US5738985A (en) * 1993-04-02 1998-04-14 Ribogene, Inc. Method for selective inactivation of viral replication
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
US5323899A (en) * 1993-06-01 1994-06-28 Welch Allyn, Inc. Case for video probe
US5435296A (en) * 1993-06-11 1995-07-25 Welch Allyn, Inc. Endoscope having crimped and soldered cable terminator
US5382533A (en) * 1993-06-18 1995-01-17 Micron Semiconductor, Inc. Method of manufacturing small geometry MOS field-effect transistors having improved barrier layer to hot electron injection
GB9315011D0 (en) * 1993-07-20 1993-09-01 British Telecomm Dispersion compensation
US5439483A (en) * 1993-10-21 1995-08-08 Ventritex, Inc. Method of quantifying cardiac fibrillation using wavelet transform
US6983051B1 (en) * 1993-11-18 2006-01-03 Digimarc Corporation Methods for audio watermarking and decoding
US5439846A (en) * 1993-12-17 1995-08-08 Sgs-Thomson Microelectronics, Inc. Self-aligned method for forming contact with zero offset to gate
US5556767A (en) 1993-12-22 1996-09-17 Human Genome Sciences, Inc. Polynucleotide encoding macrophage inflammatory protein γ
US5552329A (en) * 1994-01-05 1996-09-03 Lg Semicon Co., Ltd. Method of making metal oxide semiconductor transistors
US5519003A (en) * 1994-02-01 1996-05-21 Board Of Trustees Of The Leland Stanford Junior University WD-40-derived peptides and uses thereof
JP3423761B2 (ja) * 1994-03-02 2003-07-07 東北パイオニア株式会社 光波長変換装置
US5712111A (en) * 1994-04-15 1998-01-27 Merck & Co., Inc. DNA encoding bradykinin B1 receptor
TW387560U (en) * 1994-05-13 2000-04-11 Prec Optics Coroporation Viewing scope with image intensification
KR0141195B1 (ko) * 1994-06-08 1998-07-15 김광호 저저항 게이트전극을 갖는 반도체소자의 제조방법
US5622701A (en) * 1994-06-14 1997-04-22 Protein Design Labs, Inc. Cross-reacting monoclonal antibodies specific for E- and P-selectin
JPH0829701A (ja) * 1994-07-18 1996-02-02 Olympus Optical Co Ltd 立体視内視鏡システム
US5853975A (en) * 1994-08-23 1998-12-29 Millennium Pharmaceuticals, Inc. Methods for identifying compositions for the treatment of body weight disorders, including obesity
US6068867A (en) * 1994-11-02 2000-05-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem Protective coatings for food and agricultural products
US6221839B1 (en) * 1994-11-14 2001-04-24 Helsinki University Licensing Ltd. Oy FIt4 ligand and methods of use
US5888774A (en) * 1994-12-19 1999-03-30 Cangene Corporation Recombinant DNA molecules and expression vectors for erythropoietin
JPH08243078A (ja) * 1995-03-07 1996-09-24 Fuji Photo Optical Co Ltd 電子内視鏡の撮像素子組付け体
US5730129A (en) * 1995-04-03 1998-03-24 General Electric Company Imaging of interventional devices in a non-stationary subject
GB9506954D0 (en) * 1995-04-04 1995-05-24 Street Graham S B Method and apparatus for image enhancement
US6008325A (en) * 1995-04-19 1999-12-28 Orion Diagnostica Antibody to aminoterminal propeptide of type 1 procollagen
US5972609A (en) * 1995-04-24 1999-10-26 Medical Research Council Utrophin gene promotor
CA2221798A1 (en) * 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Colon specific genes and proteins
US5684126A (en) * 1995-06-06 1997-11-04 The Johns Hopkins University School Of Medicine Ebnerin: a secreted von Ebner's gland protein associated with taste buds
US5627848A (en) * 1995-09-05 1997-05-06 Imra America, Inc. Apparatus for producing femtosecond and picosecond pulses from modelocked fiber lasers cladding pumped with broad area diode laser arrays
US6060879A (en) * 1995-09-07 2000-05-09 Core Engineering Inc. Current magnitude sensing circuit
ATE290077T1 (de) * 1995-09-29 2005-03-15 Univ Siena Regulierte gene und ihre verwendungen
KR0169376B1 (ko) * 1995-10-10 1999-03-20 김광호 멀티미디어 대응 가능한 씨씨디 카메라 시스템
JPH09124697A (ja) * 1995-11-01 1997-05-13 Toagosei Co Ltd ペプチド及びモノクローナル抗体
KR970049406A (ko) * 1995-12-15 1997-07-29 김광호 그래픽 오버레이속도 향상기능을 갖는 화상처리장치
US6613544B1 (en) * 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6586570B1 (en) * 1996-01-11 2003-07-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US5867305A (en) * 1996-01-19 1999-02-02 Sdl, Inc. Optical amplifier with high energy levels systems providing high peak powers
US6300487B1 (en) * 1996-03-19 2001-10-09 Cell Therapuetics, Inc. Mammalian lysophosphatidic acid acyltransferase
CA2248136A1 (en) * 1996-03-21 1997-09-25 Human Genome Sciences, Inc. Human endometrial specific steroid-binding factor i, ii and iii
US6004780A (en) * 1996-03-26 1999-12-21 Human Genome Sciences, Inc. Growth factor HTTER36
US5874254A (en) * 1996-03-29 1999-02-23 Director-General Of Agency Of Industrial Science And Technology FGF-5 analogous protein, and pharmaceutical composition containing the same
US5861248A (en) * 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
ATE294863T1 (de) * 1996-07-15 2005-05-15 Chugai Pharmaceutical Co Ltd Neuartige vegf-ähnliche faktoren
US5857963A (en) * 1996-07-17 1999-01-12 Welch Allyn, Inc. Tab imager assembly for use in an endoscope
US5734418A (en) * 1996-07-17 1998-03-31 Welch Allyn, Inc. Endoscope with tab imager package
US5754313A (en) * 1996-07-17 1998-05-19 Welch Allyn, Inc. Imager assembly
US6111090A (en) * 1996-08-16 2000-08-29 Schering Corporation Mammalian cell surface antigens; related reagents
US6586210B1 (en) * 1996-08-23 2003-07-01 Human Genome Sciences, Inc. Polynucleotides encoding T1 receptor like ligand II
JP2001517075A (ja) * 1996-08-23 2001-10-02 ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ 組換え血管内皮細胞増殖因子ｄ（ｖｅｇｆ―ｄ）
US6329197B2 (en) * 1996-10-09 2001-12-11 Synaptic Pharmaceutical Corporation DNA encoding galanin GALR3 receptors and uses thereof
KR100497423B1 (ko) * 1996-10-25 2005-07-07 지.디. 썰 엘엘씨 다기능 키메라 조혈 수용체 아고니스트
US6632923B1 (en) * 1996-11-27 2003-10-14 Boston Heart Foundation, Inc. Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
US6084461A (en) * 1996-11-29 2000-07-04 Varian Medical Systems, Inc. Charge sensitive amplifier with high common mode signal rejection
AU5902398A (en) * 1996-12-31 1998-07-31 Human Genome Sciences, Inc. Cortistatin polypeptides
WO1998031818A2 (en) * 1997-01-21 1998-07-23 Human Genome Sciences, Inc. Tace-like and matrilysin-like polypeptides
US5840532A (en) * 1997-01-21 1998-11-24 Board Of Regents, The University Of Texas System Neuronal bHLH-PAS domain proteins
US5965397A (en) * 1997-01-31 1999-10-12 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US6130325A (en) * 1997-02-14 2000-10-10 Incyte Pharmaceuticals, Inc. Human P24 vesicle proteins
US5939271A (en) * 1997-02-19 1999-08-17 The Regents Of The University Of California Netrin receptor
JPH10295388A (ja) 1997-02-28 1998-11-10 Japan Tobacco Inc 哺乳動物由来生理活性タンパク
WO1998039448A2 (en) 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
EP0972029A1 (de) * 1997-03-07 2000-01-19 Human Genome Sciences, Inc. 70 humane sekretierte proteine
WO2000011014A1 (en) * 1998-08-25 2000-03-02 Human Genome Sciences, Inc. 49 human secreted proteins
US20030065139A1 (en) * 1998-03-19 2003-04-03 Craig A. Rosen Secreted protein hmmbd35
US7053190B2 (en) * 1997-03-07 2006-05-30 Human Genome Sciences, Inc. Secreted protein HRGDF73
WO2000006698A1 (en) * 1998-07-30 2000-02-10 Human Genome Sciences, Inc. 98 human secreted proteins
US6420526B1 (en) * 1997-03-07 2002-07-16 Human Genome Sciences, Inc. 186 human secreted proteins
WO1998042738A1 (en) * 1997-03-21 1998-10-01 Human Genome Sciences, Inc. 87 human secreted proteins
WO1998056804A1 (en) 1997-06-13 1998-12-17 Human Genome Sciences, Inc. 86 human secreted proteins
WO2002068628A1 (en) * 2001-02-23 2002-09-06 Human Genome Sciences, Inc. 70 human secreted proteins
US5856139A (en) * 1997-03-11 1999-01-05 Incyte Pharmaceuticals, Inc. Proline-rich acidic protein
US5989909A (en) * 1997-09-26 1999-11-23 Millennium Biotherapeutics, Inc. Huchordin and uses thereof
US20030004311A1 (en) * 1997-06-18 2003-01-02 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US5925521A (en) * 1997-03-31 1999-07-20 Incyte Pharmaceuticals, Inc. Human serine carboxypeptidase
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6088612A (en) * 1997-04-04 2000-07-11 Medtech Research Corporation Method and apparatus for reflective glare removal in digital photography useful in cervical cancer detection
US5877803A (en) * 1997-04-07 1999-03-02 Tritech Mircoelectronics International, Ltd. 3-D image detector
US20030162956A1 (en) * 1997-04-07 2003-08-28 Human Genome Sciences, Inc. Leukocyte regulatory factors 1 and 2
US20010039335A1 (en) * 1997-04-10 2001-11-08 Kenneth Jacobs Secreted proteins and polynucleotides encoding them
JP2001515361A (ja) * 1997-05-06 2001-09-18 ザイモジェネティクス，インコーポレイティド 新規な腫瘍抗原
PL193575B1 (pl) * 1997-05-15 2007-02-28 Chugai Pharmaceutical Co Ltd Zastosowanie przeciwciała przeciwko białku pokrewnemu z hormonem przytarczyc (PTHrP)
US5922567A (en) * 1997-06-03 1999-07-13 Incyte Pharmaceuticals, Inc. Two new human DNAJ-like proteins
US6525174B1 (en) * 1997-06-06 2003-02-25 Human Genome Sciences, Inc. Precerebellin-like protein
DE19726796A1 (de) * 1997-06-24 1999-01-07 Basf Ag Propylenpolymerisate
US5818630A (en) * 1997-06-25 1998-10-06 Imra America, Inc. Single-mode amplifiers and compressors based on multi-mode fibers
AU8389498A (en) * 1997-07-11 1999-02-08 Eli Lilly And Company Combinatorial process for preparing fused substituted pyrimidine libraries
ES2264207T3 (es) * 1997-07-18 2006-12-16 Zymogenetics, Inc. Homonologos proteinicos especificos de adipocitos.
US6060284A (en) * 1997-07-25 2000-05-09 Schering Corporation DNA encoding interleukin-B30
DK1000146T3 (da) * 1997-08-01 2007-01-08 Serono Genetics Inst Sa 5' EST'er for non-vævsspecifikke secernerede proteiner
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
JP2002537756A (ja) 1997-08-21 2002-11-05 ジェネティックス・インスチチュート・インコーポレーテッド 分泌蛋白
US5876963A (en) * 1997-08-27 1999-03-02 Mitchell; Peter Human nucleotide pyrophosphohydrolase
US6211904B1 (en) * 1997-09-11 2001-04-03 Edwin L. Adair Surgical devices incorporating reduced area imaging devices
ATE447583T1 (de) 1997-09-17 2009-11-15 Genentech Inc Polypeptide und dafür kodierende nukleinsäure
US6388064B1 (en) * 1997-10-06 2002-05-14 Zymogenetics, Inc. Human 2-19 protein homologue, z219a
AU1273499A (en) * 1997-10-24 1999-05-17 Human Genome Sciences, Inc. 148 human secreted proteins
US20030176681A1 (en) * 1997-10-24 2003-09-18 Ping Feng 148 human secreted proteins
US5932445A (en) * 1997-11-07 1999-08-03 Incyte Pharmaceuticals, Inc. Signal peptide-containing proteins
US6573068B1 (en) * 1997-11-13 2003-06-03 Genset, S. A. Claudin-50 protein
US6548633B1 (en) * 1998-12-22 2003-04-15 Genset, S.A. Complementary DNA's encoding proteins with signal peptides
US6025194A (en) * 1997-11-19 2000-02-15 Geron Corporation Nucleic acid sequence of senescence asssociated gene
US5972684A (en) * 1997-11-25 1999-10-26 Incyte Pharmaceuticals, Inc. Carbonic anhydrase VIII
US6194556B1 (en) * 1997-12-11 2001-02-27 Millennium Pharmaceuticals, Inc. Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therfor
WO1999031241A1 (en) * 1997-12-17 1999-06-24 Immunex Corporation Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides
US6124095A (en) * 1997-12-22 2000-09-26 Incyte Pharmaceuticals, Inc. Human nucleotide pyrophosphohydrolase-2
WO1999033963A1 (en) * 1997-12-31 1999-07-08 Chiron Corporation Metastatic cancer regulated gene
US6191809B1 (en) * 1998-01-15 2001-02-20 Vista Medical Technologies, Inc. Method and apparatus for aligning stereo images
US6607879B1 (en) * 1998-02-09 2003-08-19 Incyte Corporation Compositions for the detection of blood cell and immunological response gene expression
AU764441B2 (en) 1998-02-09 2003-08-21 Genset S.A. cDNAs encoding secreted proteins
JP2002504361A (ja) * 1998-02-26 2002-02-12 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ３６個のヒト分泌タンパク質
US6034975A (en) * 1998-03-09 2000-03-07 Imra America, Inc. High power, passively modelocked fiber laser, and method of construction
ES2312205T3 (es) 1998-03-10 2009-02-16 Genentech, Inc. Nuevo polipeptido y acidos nucleicos que lo codifican.
US6174687B1 (en) * 1999-02-26 2001-01-16 The Burnham Institute Methods of identifying lung homing molecules using membrane dipeptidase
US6245550B1 (en) * 1998-03-20 2001-06-12 Smithkline Beecham Corporation Cytokine family member EF-7
US5945308A (en) * 1998-04-03 1999-08-31 Incyte Pharmaceuticals, Inc. Human oxidized LDL receptor
ATE474849T1 (de) * 1998-04-14 2010-08-15 Chugai Pharmaceutical Co Ltd Neues cytokinartiges protein
DE19817948A1 (de) * 1998-04-17 1999-10-21 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Endometrium-Tumor
US6573095B1 (en) * 1998-04-29 2003-06-03 Genesis Research & Development Corporation Limited Polynucleotides isolated from skin cells
US6150502A (en) * 1998-04-29 2000-11-21 Genesis Research & Development Corporation Limited Polypeptides expressed in skin cells
CA2328895A1 (en) 1998-06-02 1999-12-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6800473B1 (en) * 1998-06-05 2004-10-05 Daiichi Fine Chemical Co., Ltd. Human cathepsin L2 protein, gene encoding said protein and use thereof
US20020182677A1 (en) 1998-08-03 2002-12-05 Zymogenetics, Inc. Pancreatic and ovarian polypeptide, zsig58
EP0978251B1 (de) * 1998-08-07 2005-01-26 Olympus Corporation Autoklavierbares Endoskop
US6168920B1 (en) * 1998-08-10 2001-01-02 Incyte Genomics, Inc. Extracellular adhesive proteins
EP1112285A1 (de) * 1998-08-10 2001-07-04 Genetics Institute, Inc. Menschliche chordin-verwandte proteine und dafür kodierende polynukleotide
US20030096951A1 (en) * 1998-08-14 2003-05-22 Kenneth Jacobs Secreted proteins and polynucleotides encoding them
EP1107978A1 (de) * 1998-08-24 2001-06-20 Alphagene, Inc. Sekretierte proteine und polynukleotide die sie kodieren
CA2339043A1 (en) 1998-09-01 2000-03-09 Genentech, Inc. Further pro polypeptides and sequences thereof
US7026448B2 (en) * 1998-09-01 2006-04-11 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU6142899A (en) 1998-09-10 2000-03-27 Incyte Pharmaceuticals, Inc. Human transferase proteins
US6808895B1 (en) * 1999-10-06 2004-10-26 Incyte Corporation DNA encoding oxidoreductase and polypeptide encoded thereby
US6174311B1 (en) * 1998-10-28 2001-01-16 Sdgi Holdings, Inc. Interbody fusion grafts and instrumentation
CA2348824A1 (en) * 1998-10-28 2000-05-25 Human Genome Sciences, Inc. 12 human secreted proteins
US6214582B1 (en) * 1998-11-16 2001-04-10 The Research Foundation Of State University Of Ny Y2H35 a strong IKK binding protein
US6472193B1 (en) * 1998-11-19 2002-10-29 Azwell Inc. Recombinant lysophosphatidic acid phosphatase
US6275512B1 (en) * 1998-11-25 2001-08-14 Imra America, Inc. Mode-locked multimode fiber laser pulse source
WO2001053455A2 (en) 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
AU1512900A (en) * 1998-12-09 2000-06-26 Shionogi & Co., Ltd. Human secretory phospholipase a2
JP2003521229A (ja) 1998-12-16 2003-07-15 ジェネンテック・インコーポレーテッド 分泌及び膜貫通ポリペプチドとそれをコードする核酸
US6278042B1 (en) * 1998-12-16 2001-08-21 E.I. Du Pont De Nemours And Company Plant arsenic transporters
US6184514B1 (en) * 1998-12-18 2001-02-06 Eastman Kodak Company Plastic cover for image sensors
ATE322909T1 (de) * 1998-12-21 2006-04-15 Ludwig Inst Cancer Res Antikörper gegen verkürzten vegf-d und deren verwendungen
US6172361B1 (en) * 1998-12-29 2001-01-09 Cirrus Logic, Inc. Methods for mounting an imager to a support structure and circuitry and systems embodying the same
WO2000042201A2 (en) * 1999-01-11 2000-07-20 Incyte Pharmaceuticals, Inc. Human peptidases
US20040132158A1 (en) * 1999-01-11 2004-07-08 Incyte Corporation Human peptidases
US6083152A (en) * 1999-01-11 2000-07-04 Welch Allyn, Inc. Endoscopic insertion tube
AU3208700A (en) 1999-01-19 2000-08-07 Human Genome Sciences, Inc. 33 human secreted proteins
WO2000043493A2 (en) * 1999-01-22 2000-07-27 Human Genome Sciences, Inc. Metalloproteinase adam 22
US6492505B1 (en) * 1999-02-01 2002-12-10 Incyte Genomics, Inc. Composition for detection of genes encoding membrane-associated proteins
JP2002539826A (ja) 1999-03-26 2002-11-26 スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム 新規化合物
US6331427B1 (en) * 1999-03-26 2001-12-18 Millennium Pharmaceuticals, Inc. Protease homologs
CA2383592A1 (en) 1999-03-31 2000-10-05 Curagen Corporation 2384891 acids including open reading frames encoding polypeptides; orfx
US6538732B1 (en) * 1999-05-04 2003-03-25 Everest Vit, Inc. Inspection system and method
CA2373231A1 (en) * 1999-05-19 2000-11-23 Incyte Genomics, Inc. Extracellular signaling molecules
JP2003503014A (ja) * 1999-05-20 2003-01-28 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ７回膜貫通レセプター遺伝子
US6186834B1 (en) * 1999-06-08 2001-02-13 Avaya Technology Corp. Enhanced communication connector assembly with crosstalk compensation
US6960651B2 (en) * 1999-06-29 2005-11-01 Millennium Pharmaceuticals, Inc. TANGO 332 polypeptides
US6696279B1 (en) * 1999-07-01 2004-02-24 University Of Tennessee Research Foundation Purified and isolated Mat II β subunit nucleic acids and polypeptides and therapeutic and screening methods using same
EP1396543A3 (de) 1999-07-08 2004-03-31 Research Association for Biotechnology Primer zur Synthese von vollständigen cDNA Klonen und ihre Verwendung
US6951738B2 (en) * 1999-07-16 2005-10-04 Human Genome Sciences, Inc. Human tumor necrosis factor receptors TR13 and TR14
WO2001007612A2 (en) * 1999-07-21 2001-02-01 Incyte Genomics, Inc. Receptors and associated proteins
US20050048623A1 (en) * 1999-07-21 2005-03-03 Incyte Corporation Cell cycle and proliferation proteins
EP1074617A3 (de) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
WO2001009318A1 (fr) * 1999-07-29 2001-02-08 Helix Research Institute Genes associes au cancer du foie
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins
IL147902A0 (en) * 1999-08-12 2002-08-14 Agensys Inc C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
CA2381985A1 (en) * 1999-08-16 2001-02-22 Universita'degli Studi Di Siena Vegf-d and angiogenic use thereof
US7090847B1 (en) * 1999-09-09 2006-08-15 Schering Corporation Mammalian cytokines; related reagents and methods
JP2003511012A (ja) * 1999-09-24 2003-03-25 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ３２個のヒト分泌タンパク質
CA2384713A1 (en) 1999-09-29 2001-04-05 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
AU7508100A (en) * 1999-10-04 2001-05-10 Jens Andersen Human seizure related proteins
AU7999300A (en) * 1999-10-07 2001-05-10 Zymogenetics Inc. Novel human phosphodiesterase zcytor13
US6992170B2 (en) * 1999-10-15 2006-01-31 Curagen Corporation Polypeptides and polynucleotides homologous to thymosin, ephrin a receptors, and fibromodulin
AU1449001A (en) 1999-11-05 2001-06-06 Human Genome Sciences, Inc. 28 human secreted proteins
AUPQ434899A0 (en) * 1999-11-26 1999-12-23 University Of Queensland, The Novel polynucleotide and polypeptide
JP2004522404A (ja) 1999-12-01 2004-07-29 ジェネンテック・インコーポレーテッド 分泌及び膜貫通ポリペプチドとそれをコードしている核酸
WO2001053312A1 (en) 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
US6569662B1 (en) * 2000-01-21 2003-05-27 Hyseq, Inc. Nucleic acids and polypeptides
GB0001898D0 (en) * 2000-01-27 2000-03-22 Smithkline Beecham Plc Novel compounds
EP1252298A2 (de) * 2000-01-28 2002-10-30 Incyte Genomics, Inc. Phosphodiesterasen
WO2001055317A2 (en) 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
CA2392428A1 (en) 2000-01-31 2001-08-02 Human Genome Sciences Inc. Nucleic acids, proteins, and antibodies
AU2001234944A1 (en) 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
EP1254236A2 (de) 2000-02-11 2002-11-06 Incyte Genomics, Inc. Arzneimittelmetabolisierende enzyme
JP2003523190A (ja) * 2000-02-14 2003-08-05 スミスクライン・ビーチャム・コーポレイション 新規化合物
US20060160181A1 (en) * 2000-02-15 2006-07-20 Amgen Inc. Fibroblast Growth Factor-23 molecules and uses thereof
US20020068823A1 (en) * 2000-03-24 2002-06-06 Meyers Rachel A. 33877 and 47179, novel human glycosyltransferase family members and uses thereof
EP1261638A2 (de) * 2000-03-08 2002-12-04 Chiron Corporation Humanes fgf-23 gen und genexpressionsprodukte
US6800455B2 (en) * 2000-03-31 2004-10-05 Scios Inc. Secreted factors
AU2001266557A1 (en) 2000-04-12 2001-10-23 Human Genome Sciences, Inc. Albumin fusion proteins
US7264926B2 (en) * 2000-04-18 2007-09-04 Millennium Pharmaceuticals, Inc. Nucleoside Phosphatase
WO2001085942A2 (en) * 2000-05-05 2001-11-15 Incyte Genomics, Inc. Cytoskeleton-associated proteins
US7422743B2 (en) * 2000-05-10 2008-09-09 Schering Corporation Mammalian receptor protein DCRS5;methods of treatment
WO2001090304A2 (en) 2000-05-19 2001-11-29 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
WO2001090326A2 (en) * 2000-05-22 2001-11-29 Pharmacia & Upjohn Company Novel matrix metalloproteinases
US7190705B2 (en) * 2000-05-23 2007-03-13 Imra America. Inc. Pulsed laser sources
US6429127B1 (en) * 2000-06-08 2002-08-06 Micron Technology, Inc. Methods for forming rough ruthenium-containing layers and structures/methods using same
US6590470B1 (en) * 2000-06-13 2003-07-08 Welch Allyn, Inc. Cable compensator circuit for CCD video probe
EP1176200A3 (de) * 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
EP1383892A2 (de) 2000-06-30 2004-01-28 Incyte Genomics, Inc. Humane extrazelluläre matrix- und zelladhäsions-polypeptide
ATE461213T1 (de) * 2000-07-19 2010-04-15 Advanced Res & Tech Inst Neuer fibroblastwachstumsfaktor (fgf23) und methoden zur verwendung
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
US6492281B1 (en) * 2000-09-22 2002-12-10 Advanced Micro Devices, Inc. Method of fabricating conductor structures with metal comb bridging avoidance
US20030143686A1 (en) * 2000-09-29 2003-07-31 Incyte Genomics, Inc. Transferases
US6531297B2 (en) * 2000-10-20 2003-03-11 Applera Corporation Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
US20030130485A1 (en) * 2000-11-14 2003-07-10 Meyers Rachel E. Novel human genes and methods of use thereof
EP1341804A4 (de) 2000-11-17 2005-08-24 Nuvelo Inc Neue nukleinsäuren und polypeptide
EP1397495A2 (de) 2000-12-21 2004-03-17 Millenium Pharmaceuticals, Inc. 22347, eine menschliche sulfatase und deren verwendungen
US20030148920A1 (en) 2000-12-27 2003-08-07 Steven Rosen Sulfatases and methods of use thereof
US7262797B2 (en) * 2001-02-22 2007-08-28 Ge Inspection Technologies Lp Method and system for storing calibration data within image files
US6536637B1 (en) 2001-03-16 2003-03-25 Mclaughlin Marty E. Combination backpack and water container
CA2442062A1 (en) * 2001-03-30 2002-10-10 Incyte Genomics, Inc. Secreted proteins
US7436435B2 (en) * 2001-10-01 2008-10-14 Minolta Co., Ltd. Image taking device having image-blur compensator
US6841087B2 (en) * 2002-04-19 2005-01-11 Korea Institute Of Science And Technology Refrigerant composition comprising difluoromethane, 1,1,1-trifluoroethane and 1,1,1,2-tetrafluoroethane
DE60328823D1 (de) * 2002-10-30 2009-09-24 Genentech Inc Hemmung von il-17 produktion
US20050129108A1 (en) * 2003-01-29 2005-06-16 Everest Vit, Inc. Remote video inspection system
WO2004071517A2 (en) * 2003-02-06 2004-08-26 Schering Corporation Uses of il-23 related reagents
ES2330220T3 (es) * 2003-03-10 2009-12-07 Schering Corporation Usos de antagonistas de il-23; reactivos relacionados.
US20050050707A1 (en) * 2003-09-05 2005-03-10 Scott Joshua Lynn Tip tool
EP1694864A2 (de) 2003-11-20 2006-08-30 Genentech, Inc. Zusammensetzungen und verfahren für die tumor-diagnose und behandlung
US20050162643A1 (en) * 2004-01-22 2005-07-28 Thomas Karpen Automotive fuel tank inspection device
EP1901768B1 (de) * 2004-02-17 2011-11-16 Schering Corporation Verfahren zur modulation der il-23-aktivität; relevante reagenzien
US20050287593A1 (en) * 2004-05-03 2005-12-29 Schering Corporation Use of cytokine expression to predict skin inflammation; methods of treatment
US20060050983A1 (en) * 2004-09-08 2006-03-09 Everest Vit, Inc. Method and apparatus for enhancing the contrast and clarity of an image captured by a remote viewing device
WO2006068987A2 (en) * 2004-12-20 2006-06-29 Schering Corporation Uses of il-23 antagonists in the treatment of diabetes mellitus

Also Published As

Publication number Publication date
US7193049B2 (en) 2007-03-20
US20030082702A1 (en) 2003-05-01
US20030186367A1 (en) 2003-10-02
US20030190727A1 (en) 2003-10-09
US20030077727A1 (en) 2003-04-24
US20030138888A1 (en) 2003-07-24
US20030157632A1 (en) 2003-08-21
US20030207353A1 (en) 2003-11-06
US20040126839A1 (en) 2004-07-01
US20030129695A1 (en) 2003-07-10
US20030157602A1 (en) 2003-08-21
US20020137890A1 (en) 2002-09-26
US20030199026A1 (en) 2003-10-23
US20030148426A1 (en) 2003-08-07
US20030087364A1 (en) 2003-05-08
US20030157621A1 (en) 2003-08-21
US20030148436A1 (en) 2003-08-07
US20030207362A1 (en) 2003-11-06
US20030207365A1 (en) 2003-11-06
US20030166078A1 (en) 2003-09-04
US20030207417A1 (en) 2003-11-06
US20080032332A1 (en) 2008-02-07
US20070264686A1 (en) 2007-11-15
US20030180923A1 (en) 2003-09-25
US20060257971A1 (en) 2006-11-16
US20030092106A1 (en) 2003-05-15
US20030166100A1 (en) 2003-09-04
US20030190725A1 (en) 2003-10-09
US20030207384A1 (en) 2003-11-06
US7309764B2 (en) 2007-12-18
US20030175880A1 (en) 2003-09-18
US7279552B2 (en) 2007-10-09
US20030077780A1 (en) 2003-04-24
US20030199060A1 (en) 2003-10-23
US7220831B2 (en) 2007-05-22
US20030199052A1 (en) 2003-10-23
US20030068798A1 (en) 2003-04-10
US20030180865A1 (en) 2003-09-25
US20030077785A1 (en) 2003-04-24
US20030166076A1 (en) 2003-09-04
US7291702B2 (en) 2007-11-06
US7285636B2 (en) 2007-10-23
US20030207368A1 (en) 2003-11-06
US20030077787A1 (en) 2003-04-24
US7355006B2 (en) 2008-04-08
US20030190724A1 (en) 2003-10-09
US20030190730A1 (en) 2003-10-09
US20030087357A1 (en) 2003-05-08
US20030175869A1 (en) 2003-09-18
US20030153033A1 (en) 2003-08-14
US20040009547A1 (en) 2004-01-15
US7342096B2 (en) 2008-03-11
US20080050758A1 (en) 2008-02-28
US20030170789A1 (en) 2003-09-11
US20050245730A1 (en) 2005-11-03
US20030073210A1 (en) 2003-04-17
US20030134364A1 (en) 2003-07-17
US20030207378A1 (en) 2003-11-06
US20030082711A1 (en) 2003-05-01
US20030082761A1 (en) 2003-05-01
US7189807B2 (en) 2007-03-13
US20030092108A1 (en) 2003-05-15
US7309763B2 (en) 2007-12-18
US20030158104A1 (en) 2003-08-21
US20030077788A1 (en) 2003-04-24
US20030166080A1 (en) 2003-09-04
US20030199053A1 (en) 2003-10-23
US20030157607A1 (en) 2003-08-21
US20030157611A1 (en) 2003-08-21
US20030207428A1 (en) 2003-11-06
US20030134354A1 (en) 2003-07-17
US20030082706A1 (en) 2003-05-01
US20030166075A1 (en) 2003-09-04
US20030208055A1 (en) 2003-11-06
US7390877B2 (en) 2008-06-24
US7408033B2 (en) 2008-08-05
US20030087349A1 (en) 2003-05-08
US20030082763A1 (en) 2003-05-01
US20030199033A1 (en) 2003-10-23
US20040214268A1 (en) 2004-10-28
US7312308B2 (en) 2007-12-25
US20030134368A1 (en) 2003-07-17
US7345146B2 (en) 2008-03-18
US7479545B2 (en) 2009-01-20
US20040009548A1 (en) 2004-01-15
US20030148428A1 (en) 2003-08-07
US7317074B2 (en) 2008-01-08
US20030087367A1 (en) 2003-05-08
US7220568B2 (en) 2007-05-22
US20030134367A1 (en) 2003-07-17
US20030199032A1 (en) 2003-10-23
US20030157601A1 (en) 2003-08-21
US20030082698A1 (en) 2003-05-01
US20030194772A1 (en) 2003-10-16
US20030180873A1 (en) 2003-09-25
US20030077716A1 (en) 2003-04-24
US20030082760A1 (en) 2003-05-01
US20030134376A1 (en) 2003-07-17
US20050136515A1 (en) 2005-06-23
US20030082689A1 (en) 2003-05-01
US20030199031A1 (en) 2003-10-23
US7323550B2 (en) 2008-01-29
US20030082694A1 (en) 2003-05-01
US20030077792A1 (en) 2003-04-24
US20050187379A1 (en) 2005-08-25
US7408032B2 (en) 2008-08-05
US20030082692A1 (en) 2003-05-01
US20040048333A1 (en) 2004-03-11
US20030077717A1 (en) 2003-04-24
US20030194765A1 (en) 2003-10-16
US20030199054A1 (en) 2003-10-23
US7285644B2 (en) 2007-10-23
US7524497B2 (en) 2009-04-28
US20030082709A1 (en) 2003-05-01
US20030134355A1 (en) 2003-07-17
US20030180876A1 (en) 2003-09-25
US7294705B2 (en) 2007-11-13
US7309767B2 (en) 2007-12-18
US20030082762A1 (en) 2003-05-01
US20030073212A1 (en) 2003-04-17
US7371824B2 (en) 2008-05-13
US20030207388A1 (en) 2003-11-06
US20030207420A1 (en) 2003-11-06
US7291701B2 (en) 2007-11-06
US20030207389A1 (en) 2003-11-06
US7371827B2 (en) 2008-05-13
US20030082693A1 (en) 2003-05-01
US20030138883A1 (en) 2003-07-24
US20030096386A1 (en) 2003-05-22
US20030157624A1 (en) 2003-08-21
US7282558B2 (en) 2007-10-16
US20030077728A1 (en) 2003-04-24
US20030082700A1 (en) 2003-05-01
US7342104B2 (en) 2008-03-11
US20030199057A1 (en) 2003-10-23
US20030054517A1 (en) 2003-03-20
US20030134365A1 (en) 2003-07-17
US20030207349A1 (en) 2003-11-06
US20030148434A1 (en) 2003-08-07
US20040058424A1 (en) 2004-03-25
US7704496B2 (en) 2010-04-27
US20030207359A1 (en) 2003-11-06
US7314920B2 (en) 2008-01-01
US20030087361A1 (en) 2003-05-08
US20030157612A1 (en) 2003-08-21
US20030166082A1 (en) 2003-09-04
US7087428B2 (en) 2006-08-08
US7361337B2 (en) 2008-04-22
US7291329B2 (en) 2007-11-06
US7309778B2 (en) 2007-12-18
US20030138893A1 (en) 2003-07-24
US7291700B2 (en) 2007-11-06
US20030138886A1 (en) 2003-07-24
US20030203462A1 (en) 2003-10-30
US20030166096A1 (en) 2003-09-04
US20030194774A1 (en) 2003-10-16
US7279551B2 (en) 2007-10-09
US7309762B2 (en) 2007-12-18
US7354998B2 (en) 2008-04-08
US20030092105A1 (en) 2003-05-15
US20040033558A1 (en) 2004-02-19
US20030166081A1 (en) 2003-09-04
US20030180866A1 (en) 2003-09-25
US20030134374A1 (en) 2003-07-17
US20030207426A1 (en) 2003-11-06
US20030199023A1 (en) 2003-10-23
US7326413B2 (en) 2008-02-05
US20030134358A1 (en) 2003-07-17
US20030082696A1 (en) 2003-05-01
US20030207356A1 (en) 2003-11-06
US7335745B2 (en) 2008-02-26
US20030148435A1 (en) 2003-08-07
US20030166087A1 (en) 2003-09-04
US7396907B2 (en) 2008-07-08
US20030073214A1 (en) 2003-04-17
US20030134791A1 (en) 2003-07-17
US20030194773A1 (en) 2003-10-16
US7247710B2 (en) 2007-07-24
US20030194792A1 (en) 2003-10-16
US20030134384A1 (en) 2003-07-17
US20030157603A1 (en) 2003-08-21
US20030186366A1 (en) 2003-10-02
US20030207357A1 (en) 2003-11-06
US20030194791A1 (en) 2003-10-16
US7301007B2 (en) 2007-11-27
US20030077720A1 (en) 2003-04-24
US20030077776A1 (en) 2003-04-24
US7309766B2 (en) 2007-12-18
US20030092103A1 (en) 2003-05-15
US20030199030A1 (en) 2003-10-23
US7318922B2 (en) 2008-01-15
US20030190718A1 (en) 2003-10-09
US20030194777A1 (en) 2003-10-16
US20050164279A1 (en) 2005-07-28
US20030077725A1 (en) 2003-04-24
US20030077790A1 (en) 2003-04-24
US20030148424A1 (en) 2003-08-07
US7390883B2 (en) 2008-06-24
US7351793B2 (en) 2008-04-01
US7495082B2 (en) 2009-02-24
US20030082764A1 (en) 2003-05-01
US20030082704A1 (en) 2003-05-01
US7425621B2 (en) 2008-09-16
US20030087366A1 (en) 2003-05-08
US20030078377A1 (en) 2003-04-24
US7378502B2 (en) 2008-05-27
US20030203440A1 (en) 2003-10-30
US20030087363A1 (en) 2003-05-08
US20030180864A1 (en) 2003-09-25
US7285626B2 (en) 2007-10-23
US7282560B2 (en) 2007-10-16
US20030203439A1 (en) 2003-10-30
US7396916B2 (en) 2008-07-08
US20030194771A1 (en) 2003-10-16
US20030054516A1 (en) 2003-03-20
US20030049816A1 (en) 2003-03-13
US7408042B2 (en) 2008-08-05
US20030207423A1 (en) 2003-11-06
US20030203437A1 (en) 2003-10-30
US7390887B2 (en) 2008-06-24
US20030190722A1 (en) 2003-10-09
US7189534B2 (en) 2007-03-13
US20030087362A1 (en) 2003-05-08
US20030077726A1 (en) 2003-04-24
US20030203429A1 (en) 2003-10-30
US20030148429A1 (en) 2003-08-07
US20030207355A1 (en) 2003-11-06
US20030077781A1 (en) 2003-04-24
US20030077777A1 (en) 2003-04-24
US20030207361A1 (en) 2003-11-06
US20030157614A1 (en) 2003-08-21
US7429640B2 (en) 2008-09-30
US7304140B2 (en) 2007-12-04
US20030092111A1 (en) 2003-05-15
US20030148425A1 (en) 2003-08-07
US7074910B2 (en) 2006-07-11
US20030073215A1 (en) 2003-04-17
US20030087358A1 (en) 2003-05-08
US20030170790A1 (en) 2003-09-11
US20030073213A1 (en) 2003-04-17
US20030129690A1 (en) 2003-07-10
US20030036180A1 (en) 2003-02-20
US20050202496A1 (en) 2005-09-15
US20030087345A1 (en) 2003-05-08
US20030207352A1 (en) 2003-11-06
US20030148439A1 (en) 2003-08-07
US20030166098A1 (en) 2003-09-04
US20030087353A1 (en) 2003-05-08
US7282566B2 (en) 2007-10-16
US20030134375A1 (en) 2003-07-17
US7700736B2 (en) 2010-04-20
US20030077714A1 (en) 2003-04-24
US20030087355A1 (en) 2003-05-08
US20030194776A1 (en) 2003-10-16
US20030157616A1 (en) 2003-08-21
US7294692B2 (en) 2007-11-13
ZA200404849B (en) 2006-05-31
US20030119103A1 (en) 2003-06-26
US20030082708A1 (en) 2003-05-01
US20030148430A1 (en) 2003-08-07
US7304133B2 (en) 2007-12-04
US20030134366A1 (en) 2003-07-17
US20030148431A1 (en) 2003-08-07
US7317088B2 (en) 2008-01-08
US20030194779A1 (en) 2003-10-16
US20030199051A1 (en) 2003-10-23
US20030199055A1 (en) 2003-10-23
US20030166091A1 (en) 2003-09-04
US7323545B2 (en) 2008-01-29
US20030082686A1 (en) 2003-05-01
US20030207381A1 (en) 2003-11-06
US7098003B2 (en) 2006-08-29
US7385031B2 (en) 2008-06-10
US20030138885A1 (en) 2003-07-24
US20030134377A1 (en) 2003-07-17
US20030166095A1 (en) 2003-09-04
US20030203431A1 (en) 2003-10-30
US7335728B2 (en) 2008-02-26
US20030157629A1 (en) 2003-08-21
US20030190717A1 (en) 2003-10-09
US20030207414A1 (en) 2003-11-06
US7342097B2 (en) 2008-03-11
US20030082766A1 (en) 2003-05-01
US20030207383A1 (en) 2003-11-06
US20030082712A1 (en) 2003-05-01
US20030157630A1 (en) 2003-08-21
US20030199062A1 (en) 2003-10-23
US20030207363A1 (en) 2003-11-06
US20030157627A1 (en) 2003-08-21
US8106156B2 (en) 2012-01-31
US20030207364A1 (en) 2003-11-06
US20050019823A1 (en) 2005-01-27
US7288625B2 (en) 2007-10-30
US7297765B2 (en) 2007-11-20
US20030077786A1 (en) 2003-04-24
US20030166102A1 (en) 2003-09-04
US20030153034A1 (en) 2003-08-14
US20030148438A1 (en) 2003-08-07
US20030082765A1 (en) 2003-05-01
US20030092113A1 (en) 2003-05-15
US20030207350A1 (en) 2003-11-06
US20030129694A1 (en) 2003-07-10
US20030082703A1 (en) 2003-05-01
US20030207418A1 (en) 2003-11-06
US20030134379A1 (en) 2003-07-17
US7411040B2 (en) 2008-08-12
US7312307B2 (en) 2007-12-25
US20030194794A1 (en) 2003-10-16
US20030092147A1 (en) 2003-05-15
US20030194766A1 (en) 2003-10-16
US7329730B2 (en) 2008-02-12
US7390878B2 (en) 2008-06-24
US20030134359A1 (en) 2003-07-17
US20060084139A1 (en) 2006-04-20
US20030194793A1 (en) 2003-10-16
US20030157605A1 (en) 2003-08-21
US20030199028A1 (en) 2003-10-23
US20030199061A1 (en) 2003-10-23
US20030203432A1 (en) 2003-10-30
US7504484B2 (en) 2009-03-17
US20030134360A1 (en) 2003-07-17
US7309777B2 (en) 2007-12-18
US20030175878A1 (en) 2003-09-18
US7417115B2 (en) 2008-08-26
US20030134362A1 (en) 2003-07-17
US7317081B2 (en) 2008-01-08
US7566774B2 (en) 2009-07-28
US20030207415A1 (en) 2003-11-06
US20040214265A1 (en) 2004-10-28
US7311909B2 (en) 2007-12-25
US20030032156A1 (en) 2003-02-13
US20030134380A1 (en) 2003-07-17
US20030134369A1 (en) 2003-07-17
US7312313B2 (en) 2007-12-25
US20030157613A1 (en) 2003-08-21
US20030087354A1 (en) 2003-05-08
US20030166101A1 (en) 2003-09-04
US20030134363A1 (en) 2003-07-17
US20030211571A1 (en) 2003-11-13
US20030194767A1 (en) 2003-10-16
US7425609B2 (en) 2008-09-16
US20030017563A1 (en) 2003-01-23
US20030166084A1 (en) 2003-09-04
US20030207360A1 (en) 2003-11-06
US7335740B2 (en) 2008-02-26
US20030082710A1 (en) 2003-05-01
US20030129692A1 (en) 2003-07-10
US20040039164A1 (en) 2004-02-26
US7718173B2 (en) 2010-05-18
US20030138887A1 (en) 2003-07-24
US20050153396A1 (en) 2005-07-14
US20030134356A1 (en) 2003-07-17
US20030166094A1 (en) 2003-09-04
US20030207367A1 (en) 2003-11-06
US7335746B2 (en) 2008-02-26
US20030032155A1 (en) 2003-02-13
US20030175871A1 (en) 2003-09-18
US20030194775A1 (en) 2003-10-16
US20030194770A1 (en) 2003-10-16
US20030077718A1 (en) 2003-04-24
US7189806B2 (en) 2007-03-13
US20030077724A1 (en) 2003-04-24
US20050074837A1 (en) 2005-04-07
US20040038335A1 (en) 2004-02-26
US20030175868A1 (en) 2003-09-18
US20030082759A1 (en) 2003-05-01
US20030134378A1 (en) 2003-07-17
US7351794B2 (en) 2008-04-01
US20030087346A1 (en) 2003-05-08
US20030087385A1 (en) 2003-05-08
US7521539B2 (en) 2009-04-21
US7276577B2 (en) 2007-10-02
US7357926B2 (en) 2008-04-15
US20030180870A1 (en) 2003-09-25
US20030175866A1 (en) 2003-09-18
US20030134373A1 (en) 2003-07-17
US20090209732A1 (en) 2009-08-20
US20060040351A1 (en) 2006-02-23
US20030157608A1 (en) 2003-08-21
US20030207424A1 (en) 2003-11-06
US7285629B2 (en) 2007-10-23
US7342098B2 (en) 2008-03-11
US20030100087A1 (en) 2003-05-29
US7109305B2 (en) 2006-09-19
US20030199025A1 (en) 2003-10-23
US20030175877A1 (en) 2003-09-18
US20030203428A1 (en) 2003-10-30
US7297764B2 (en) 2007-11-20
US7319136B2 (en) 2008-01-15
US20030175879A1 (en) 2003-09-18
US20030148427A1 (en) 2003-08-07
US20060084138A1 (en) 2006-04-20
US7202345B2 (en) 2007-04-10
US20030207376A1 (en) 2003-11-06
US7294495B2 (en) 2007-11-13
US20040214267A1 (en) 2004-10-28
US20030087351A1 (en) 2003-05-08
US20030077715A1 (en) 2003-04-24
US20030207366A1 (en) 2003-11-06
US20030207427A1 (en) 2003-11-06
US20030082691A1 (en) 2003-05-01
US20030180874A1 (en) 2003-09-25
US20030190728A1 (en) 2003-10-09
US7335729B2 (en) 2008-02-26
US20030082687A1 (en) 2003-05-01
US7273926B2 (en) 2007-09-25
US20030087348A1 (en) 2003-05-08
US20030207387A1 (en) 2003-11-06
US20030207370A1 (en) 2003-11-06
US20040253667A1 (en) 2004-12-16
US20030180875A1 (en) 2003-09-25
US20030166083A1 (en) 2003-09-04
US20050136475A1 (en) 2005-06-23
US20030077778A1 (en) 2003-04-24
US20030190726A1 (en) 2003-10-09
US20030166077A1 (en) 2003-09-04
US20030082695A1 (en) 2003-05-01
US20030082701A1 (en) 2003-05-01
US20030134357A1 (en) 2003-07-17
US20030068794A1 (en) 2003-04-10
US20030166074A1 (en) 2003-09-04
US20030166085A1 (en) 2003-09-04
US7309768B2 (en) 2007-12-18
US20030129689A1 (en) 2003-07-10
US20030157623A1 (en) 2003-08-21
US20030166071A1 (en) 2003-09-04
US20030068793A1 (en) 2003-04-10
US7297768B2 (en) 2007-11-20
US7385030B2 (en) 2008-06-10
US20030082705A1 (en) 2003-05-01
US20030044945A1 (en) 2003-03-06
US20030157631A1 (en) 2003-08-21
US20030157619A1 (en) 2003-08-21
US20030166092A1 (en) 2003-09-04
US20030199064A1 (en) 2003-10-23
US20030180879A1 (en) 2003-09-25
US7396906B2 (en) 2008-07-08
US20030199056A1 (en) 2003-10-23
US20040077064A1 (en) 2004-04-22
US7390486B2 (en) 2008-06-24
US7307151B2 (en) 2007-12-11
US20030077722A1 (en) 2003-04-24
US20070026487A1 (en) 2007-02-01
US20030219885A1 (en) 2003-11-27
US20050214846A1 (en) 2005-09-29
US20030203430A1 (en) 2003-10-30
US20030143674A1 (en) 2003-07-31
US20030077783A1 (en) 2003-04-24
US20030190719A1 (en) 2003-10-09
US7343721B2 (en) 2008-03-18
US20030138889A1 (en) 2003-07-24
US20070224185A1 (en) 2007-09-27
US7329404B2 (en) 2008-02-12
US20030082697A1 (en) 2003-05-01
US20030082690A1 (en) 2003-05-01
US20030157604A1 (en) 2003-08-21
US7166703B2 (en) 2007-01-23
US20040033559A1 (en) 2004-02-19
US20030207373A1 (en) 2003-11-06
US20090142786A1 (en) 2009-06-04
US7417123B2 (en) 2008-08-26
US20030077721A1 (en) 2003-04-24
US20030157606A1 (en) 2003-08-21
US20030175865A1 (en) 2003-09-18
US7105335B2 (en) 2006-09-12
US20030207385A1 (en) 2003-11-06
US20030190720A1 (en) 2003-10-09
US7312314B2 (en) 2007-12-25
US20030068795A1 (en) 2003-04-10
US7291715B2 (en) 2007-11-06
KR20040074090A (ko) 2004-08-21
US20030036179A1 (en) 2003-02-20
US20030199063A1 (en) 2003-10-23
US20030077779A1 (en) 2003-04-24
US20030073211A1 (en) 2003-04-17
US20030077713A1 (en) 2003-04-24
US20030077719A1 (en) 2003-04-24
US20030207429A1 (en) 2003-11-06
US7153941B2 (en) 2006-12-26
US20030199027A1 (en) 2003-10-23
US20030134385A1 (en) 2003-07-17
US20030157622A1 (en) 2003-08-21
US7348414B2 (en) 2008-03-25
US20030180868A1 (en) 2003-09-25
US20060194283A1 (en) 2006-08-31
US20030175872A1 (en) 2003-09-18
US20030190721A1 (en) 2003-10-09
US7304132B2 (en) 2007-12-04
US7285627B2 (en) 2007-10-23
US20030077789A1 (en) 2003-04-24
US7285628B2 (en) 2007-10-23
US20030148432A1 (en) 2003-08-07
US7317079B2 (en) 2008-01-08
US20030207390A1 (en) 2003-11-06
US20030087352A1 (en) 2003-05-08
US20030207425A1 (en) 2003-11-06
US20030166088A1 (en) 2003-09-04
US20030166093A1 (en) 2003-09-04
US20030180878A1 (en) 2003-09-25
US20030194768A1 (en) 2003-10-16
US7312312B2 (en) 2007-12-25
US20030157620A1 (en) 2003-08-21
US7297766B2 (en) 2007-11-20
US20030148423A1 (en) 2003-08-07
US7291717B2 (en) 2007-11-06
US20030157628A1 (en) 2003-08-21
US20030022328A1 (en) 2003-01-30
US20030134382A1 (en) 2003-07-17
US20030022331A1 (en) 2003-01-30
US20050170396A1 (en) 2005-08-04
US20030073216A1 (en) 2003-04-17
US7432345B2 (en) 2008-10-07
US20030207416A1 (en) 2003-11-06
US20030175874A1 (en) 2003-09-18
US7141652B1 (en) 2006-11-28
US20030077711A1 (en) 2003-04-24
US20030157626A1 (en) 2003-08-21
US20040214269A1 (en) 2004-10-28
US7361732B2 (en) 2008-04-22
US7635478B2 (en) 2009-12-22
US20030157610A1 (en) 2003-08-21
US20040029217A1 (en) 2004-02-12
US20030194778A1 (en) 2003-10-16
US7319135B2 (en) 2008-01-15
US7294703B2 (en) 2007-11-13
US20030190723A1 (en) 2003-10-09
US20060084144A1 (en) 2006-04-20
US20030166090A1 (en) 2003-09-04
US20030190729A1 (en) 2003-10-09
US20030077710A1 (en) 2003-04-24
US20030207422A1 (en) 2003-11-06
US7323544B2 (en) 2008-01-29
US20030157617A1 (en) 2003-08-21
US7304131B2 (en) 2007-12-04
US20030148433A1 (en) 2003-08-07
US20030166089A1 (en) 2003-09-04
US20030207421A1 (en) 2003-11-06
US20030077659A1 (en) 2003-04-24
US20030175873A1 (en) 2003-09-18
US20030175867A1 (en) 2003-09-18
US7309765B2 (en) 2007-12-18
US20030087360A1 (en) 2003-05-08
US20060073568A1 (en) 2006-04-06
US20030087350A1 (en) 2003-05-08
US7411047B2 (en) 2008-08-12
US7439325B2 (en) 2008-10-21
US7355007B2 (en) 2008-04-08
US20030170788A1 (en) 2003-09-11
US7288626B2 (en) 2007-10-30
US7294702B2 (en) 2007-11-13
US20030207354A1 (en) 2003-11-06
US20030207379A1 (en) 2003-11-06
US7291716B2 (en) 2007-11-06
US7160993B2 (en) 2007-01-09
US7084258B2 (en) 2006-08-01
US20030148437A1 (en) 2003-08-07
US20030134361A1 (en) 2003-07-17
US20030077791A1 (en) 2003-04-24
US20030092107A1 (en) 2003-05-15
US20030087365A1 (en) 2003-05-08
US20030175875A1 (en) 2003-09-18
US20030092110A1 (en) 2003-05-15
US20030077723A1 (en) 2003-04-24
US20030087356A1 (en) 2003-05-08
US20030087359A1 (en) 2003-05-08
US7449554B2 (en) 2008-11-11
US20030134370A1 (en) 2003-07-17
US20050118635A1 (en) 2005-06-02
US20030199058A1 (en) 2003-10-23
US20040253666A1 (en) 2004-12-16
US20030077712A1 (en) 2003-04-24
US20030207374A1 (en) 2003-11-06
US7288627B2 (en) 2007-10-30
US20030207351A1 (en) 2003-11-06
US7488586B2 (en) 2009-02-10
US20030180871A1 (en) 2003-09-25
US7317080B2 (en) 2008-01-08
US20030207358A1 (en) 2003-11-06
US7468427B2 (en) 2008-12-23
US20030134383A1 (en) 2003-07-17
US20030059909A1 (en) 2003-03-27
US20030068796A1 (en) 2003-04-10
US20030082699A1 (en) 2003-05-01
US20030157618A1 (en) 2003-08-21
US20030068797A1 (en) 2003-04-10
US20030138891A1 (en) 2003-07-24
US20030077784A1 (en) 2003-04-24
US20030092115A1 (en) 2003-05-15
US20030129693A1 (en) 2003-07-10
US20030199029A1 (en) 2003-10-23
US20050153348A1 (en) 2005-07-14
US7294693B2 (en) 2007-11-13
US20030175870A1 (en) 2003-09-18
US7375195B2 (en) 2008-05-20
US20030138892A1 (en) 2003-07-24
US20040203125A1 (en) 2004-10-14
US20030207386A1 (en) 2003-11-06
US20030199059A1 (en) 2003-10-23
US20030134372A1 (en) 2003-07-17
US20030166086A1 (en) 2003-09-04
US20030049817A1 (en) 2003-03-13
US7282559B2 (en) 2007-10-16
US20040235092A1 (en) 2004-11-25
US20030157609A1 (en) 2003-08-21
US20030207419A1 (en) 2003-11-06
US20030092104A1 (en) 2003-05-15
US20030207377A1 (en) 2003-11-06
ATE408419T1 (de) 2008-10-15
US20030087347A1 (en) 2003-05-08
US20030207382A1 (en) 2003-11-06
US20030134381A1 (en) 2003-07-17
US20040038336A1 (en) 2004-02-26
US7189813B2 (en) 2007-03-13
US20030194769A1 (en) 2003-10-16
US20030207371A1 (en) 2003-11-06
US20030190731A1 (en) 2003-10-09
US20030207369A1 (en) 2003-11-06
US7306795B2 (en) 2007-12-11
US20030077782A1 (en) 2003-04-24

Similar Documents

Publication Publication Date Title
ATE408419T1 (de) Zusammensetzungen und verfahren zur diagnose und behandlung eines tumors
ATE357518T1 (de) Verfahren und zusammensetzungen zur inhibierung des neoplastischen zellwachstums
DE69940964D1 (de) Verfahren und Zusammensetzungen zur Hemmung des neoplastischen Zellenwachstums
CY1112334T1 (el) Ομολογα πολυπεπτιδια il-17 και θεραπευτικες χρησεις αυτων
EP1690873A3 (de) Zusammensetzung und Verfahren zur Diagnose eines Tumors
ATE478145T1 (de) Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren
ATE447583T1 (de) Polypeptide und dafür kodierende nukleinsäure
ATE329023T1 (de) Ausgeschiedene und transmembran-polypeptide und dafür kodierende nukleinsäure
IL155567A0 (en) Method of diagnosing and treating cartilaginous disorders
ATE320484T1 (de) Histone-deacetylase-8 proteine, nukleinsäuren und methoden zur verwendung
DK1366161T3 (da) Antagonist anti-PRO842-antistof
DE60018605D1 (de) Ing2, ein mit iaps assoziiertes zellzyklusprotein, sowie zusammensetzungen, verfahren und verwendungen
EP1666594A3 (de) Polypeptide, dafür kodierende Nukleinsäuren, und deren Verwendung zur Diagnose von Krebs
WO2000007545A3 (en) Apoptosis proteins
EP1657254A3 (de) Polypeptide, dafür kodierende Nukleinsäuren und deren Verwendung zur Diagnose von Krebs
DE69937756D1 (de) Menschliches Prostasin-ähnliches Protein und dafür kodierende Nukleinsäure
DE69939339D1 (de) Menschliches Synaptogyrin-ähnliches Protein und dafür kodierende Nukleinsäure
DE69939403D1 (de) Menschliches HCAR-ähnliches Protein und dafür kodierende Nukleinsäure
DE69939227D1 (de) Menschliches A33-Antigen-ähnliches Protein und dafür kodierende Nukleinsäure
ATE300553T1 (de) Sekretiertes polypeptide und dafür kodierende nukleinsäuren
DE60038986D1 (de) Ausgeschiedene und Transmembranpolypeptide und dafür kodierende Nukleinsäure
ATE363537T1 (de) Ausgeschiedene und transmembranpolypeptide und dafür kodierende nukleinsäure

Legal Events

Date Code Title Description
8364 No opposition during term of opposition